<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ther Adv Psychopharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ther Adv Psychopharmacol</journal-id>
<journal-id journal-id-type="publisher-id">TPP</journal-id>
<journal-id journal-id-type="hwp">sptpp</journal-id>
<journal-title-group>
<journal-title>Therapeutic Advances in Psychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">2045-1253</issn>
<issn pub-type="epub">2045-1261</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30800283</article-id>
<article-id pub-id-type="pmc">6378634</article-id>
<article-id pub-id-type="doi">10.1177/2045125318814734</article-id>
<article-id pub-id-type="publisher-id">10.1177_2045125318814734</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic risk factors for eating disorders: an update and insights into pathophysiology</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Himmerich</surname>
<given-names>Hubertus</given-names>
</name>
<aff id="aff1-2045125318814734">Department of Psychological Medicine, King’s College London, London, UK</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bentley</surname>
<given-names>Jessica</given-names>
</name>
<aff id="aff2-2045125318814734">Department of Psychological Medicine, King’s College London, London, UK</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kan</surname>
<given-names>Carol</given-names>
</name>
<aff id="aff3-2045125318814734">Department of Psychological Medicine, King’s College London, London, UK</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Treasure</surname>
<given-names>Janet</given-names>
</name>
<xref ref-type="corresp" rid="corresp1-2045125318814734"></xref>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-2045125318814734">
<email>janet.treasure@kcl.ac.uk</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>9</volume>
<elocation-id>2045125318814734</elocation-id>
<history>
<date date-type="received">
<day>5</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s), 2019</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder content-type="sage">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder>
<license license-type="creative-commons" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Genome-wide-association studies (GWASs), epigenetic, gene-expression and gene–gene interaction projects, nutritional genomics and investigations of the gut microbiota have increased our knowledge of the pathophysiology of eating disorders (EDs). However, compared with anorexia nervosa, genetic studies in patients with bulimia nervosa and binge-eating disorder are relatively scarce, with the exception of a few formal genetic and small-sized candidate–gene-association studies. In this article, we review important findings derived from formal and molecular genetics in order to outline a genetics-based pathophysiological model of EDs. This model takes into account environmental and nutritional factors, genetic factors related to the microbiome, the metabolic and endocrine system, the immune system, and the brain, in addition to phenotypical traits of EDs. Shortcomings and advantages of genetic research in EDs are discussed against the historical background, but also in light of potential future treatment options for patients with EDs.</p>
</abstract>
<kwd-group>
<kwd>anorexia nervosa</kwd>
<kwd>binge-eating disorder</kwd>
<kwd>bulimia nervosa</kwd>
<kwd>genetics</kwd>
<kwd>GWAS</kwd>
<kwd>microbiome</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January-December 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="section1-2045125318814734" sec-type="intro">
<title>Introduction</title>
<sec id="section2-2045125318814734">
<title>Historical reflection on psychiatric genetics</title>
<p>Ancestry plays a decisive role in early historic attempts to create a sense of purpose and identity. This approach is found in several religions, including prehistoric cults, Buddhism, Islam, Judaism and Christianity.<sup><xref ref-type="bibr" rid="bibr1-2045125318814734">1</xref></sup> In the book of Genesis, for example, which was reportedly written in the 5th and 4th centuries BC, the descendants of Abraham are recorded.<sup><xref ref-type="bibr" rid="bibr2-2045125318814734">2</xref></sup> One way to interpret such genealogies may be to value them as early evidence of the idea that ancestry comes with the inheritance of traits, characteristics and competences that indicate individuals for certain assignments.</p>
<p>However, the first significant step towards scientific genetics was made by Gregor Johann Mendel (1822–1884), who gained posthumous recognition as the founder of formal genetics for conducting and publishing the results of his ‘experiments in plant hybridization’, from which he demonstrated dominant and recessive inheritance.<sup><xref ref-type="bibr" rid="bibr3-2045125318814734">3</xref></sup> In psychiatry, formal genetics became an important research focus in the early 20th century<sup><xref ref-type="bibr" rid="bibr4-2045125318814734">4</xref>,<xref ref-type="bibr" rid="bibr5-2045125318814734">5</xref></sup> leading to compulsory sterilization of the mentally ill to prevent the occurrence of mental disorders.<sup><xref ref-type="bibr" rid="bibr6-2045125318814734">6</xref></sup> In this context, it is important to mention Ernst Rüdin (1874–1952), a member of the German Nazi Party, who has been credited as the originator of modern psychiatric genetics.<sup><xref ref-type="bibr" rid="bibr7-2045125318814734">7</xref></sup> He promoted the prevention of assumed hereditary mental illnesses by the prohibition of marriage or sterilization,<sup><xref ref-type="bibr" rid="bibr8-2045125318814734">8</xref></sup> despite his knowledge that major mental disorders, including affective disorders, do not follow a simple pattern of Mendelian inheritance.<sup><xref ref-type="bibr" rid="bibr9-2045125318814734">9</xref></sup></p>
<p>The next major step in scientific genetics following the discovery of statistical patterns of inheritance was to elucidate the molecular basis of heredity. Deoxyribonucleic acid (DNA), the molecule that carries genetic information, was first isolated in 1869 by the Swiss physician Friedrich Miescher (1844–1895) and termed ‘nuclein’.<sup><xref ref-type="bibr" rid="bibr10-2045125318814734">10</xref></sup> In 1953, Watson and Crick suggested the double-helix structure of this molecule.<sup><xref ref-type="bibr" rid="bibr11-2045125318814734">11</xref></sup> Further work by Crick and coworkers showed that the genetic code was based on nonoverlapping triplets of bases, allowing Khorana and colleagues to decipher this genetic code.<sup><xref ref-type="bibr" rid="bibr12-2045125318814734">12</xref></sup> These developments laid the foundations for genetic association studies, which have been used to identify candidate genes or genome regions that were hypothesized as contributing to a specific disease.<sup><xref ref-type="bibr" rid="bibr13-2045125318814734">13</xref></sup> In the 1980s, early molecular genetic studies in psychiatry focused on candidate genes that were considered to be involved in neurotransmitter metabolism, neurotransmitter receptors and neuropeptides.<sup><xref ref-type="bibr" rid="bibr14-2045125318814734">14</xref></sup> However, the candidate–gene approach is currently regarded as obsolete and problematic in the field of psychiatry due to its insufficient statistical power and difficulties with replication.</p>
<p>Around the turn of the millennium, researchers began to investigate the entire genome in a noncandidate-driven approach by performing genome-wide association studies (GWASs). The first successful GWAS was published by Klein and colleagues in 2005 on age-related macular degeneration.<sup><xref ref-type="bibr" rid="bibr15-2045125318814734">15</xref></sup> Since then, ~4000 human GWASs have examined ~2000 diseases and traits, and thousands of single-nucleotide polymorphism (SNP) associations have been identified.<sup><xref ref-type="bibr" rid="bibr16-2045125318814734">16</xref></sup> As GWASs require a large number of study participants, study centres need to forge consortia in order to achieve those numbers. As a result, the Psychiatric Genomics Consortium (PGC) has become the largest consortium in the history of psychiatry. The PGC is dedicated to elucidating the fundamental biology of psychiatric disorders, informing clinical practice, and delivering novel therapeutic targets on the basis of genomic research<sup><xref ref-type="bibr" rid="bibr16-2045125318814734">16</xref></sup> with GWASs currently being the gold standard and the workhorse of psychiatric genetics.</p>
<p>In 1986, Hegstrand and Hine published a groundbreaking study wherein they demonstrated significant differences in hypothalamic histamine levels between germ-free and conventionally raised animals.<sup><xref ref-type="bibr" rid="bibr17-2045125318814734">17</xref></sup> Thus, they proved that microbes influence brain chemistry<sup><xref ref-type="bibr" rid="bibr18-2045125318814734">18</xref></sup> and specifically, histaminergic neurotransmission, which is particularly important for appetite and weight regulation.<sup><xref ref-type="bibr" rid="bibr17-2045125318814734">17</xref>,<xref ref-type="bibr" rid="bibr19-2045125318814734">19</xref></sup> From the 1980s until now, multiple important synergistic activities between humans and the microbes living in and on them have been identified;<sup><xref ref-type="bibr" rid="bibr20-2045125318814734">20</xref><xref ref-type="bibr" rid="bibr21-2045125318814734"></xref><xref ref-type="bibr" rid="bibr22-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr23-2045125318814734">23</xref></sup> as a result, following completion of the human genome sequence, researchers felt that the achievement was incomplete, as it neglected the genetic material of the microbiota. Therefore, they called for the Human Microbiome Project as a ‘second human genome project’ that ‘would entail a comprehensive inventory of microbial genes and genomes at the four major sites of microbial colonization in the human body: mouth, gut, vagina, and skin’.<sup><xref ref-type="bibr" rid="bibr21-2045125318814734">21</xref></sup> As there is substantial evidence on the significance of the ecological community of microorganisms that share our body space,<sup><xref ref-type="bibr" rid="bibr20-2045125318814734">20</xref><xref ref-type="bibr" rid="bibr21-2045125318814734"></xref><xref ref-type="bibr" rid="bibr22-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr23-2045125318814734">23</xref></sup> this review on genetic risk factors for eating disorders (EDs) will also take into account the microbiome, which comprises the genetic material within our microbiota.</p>
<p>The latest genetic research in the field of EDs does not stop at examining the triplets of bases of DNA sequences in human cells and other organisms within the human body and contributing to its function, it also takes considers gene function, gene expression, gene–gene interaction and the interaction between genes and food.</p>
</sec>
<sec id="section3-2045125318814734">
<title>Eating disorders</title>
<p>EDs are characterized by a persistent disrupted eating behaviour, which leads to changes in dietary intake, impaired physical health and psychosocial problems. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) currently recognises three primary EDs: anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED).<sup><xref ref-type="bibr" rid="bibr24-2045125318814734">24</xref></sup> Additionally, the DSM-5 mentions avoidant/restrictive food-intake disorder (ARFID; an eating disturbance manifested by a restrictive eating pattern with persistent failure to meet appropriate nutritional needs), pica (the consumption of nonfood) and rumination disorder (regurgitation and rechewing food).<sup><xref ref-type="bibr" rid="bibr24-2045125318814734">24</xref>,<xref ref-type="bibr" rid="bibr25-2045125318814734">25</xref></sup> However, as we are not aware of any genetic research on ARFID, pica or rumination disorder, the current review will not focus on these conditions.</p>
<p>The main criteria for the diagnosis of AN are a significantly low body weight in the context of age, sex, and physical health, intense fear of weight gain and disturbed body perception.<sup><xref ref-type="bibr" rid="bibr24-2045125318814734">24</xref>,<xref ref-type="bibr" rid="bibr25-2045125318814734">25</xref></sup> The dietary deficit is often accompanied by significant physical health issues, including growth retardation, osteopenia, amenorrhoea and renal insufficiency, in addition to changes in laboratory parameters, cardiac arrhythmia and disturbances of thyroid function.<sup><xref ref-type="bibr" rid="bibr26-2045125318814734">26</xref></sup> The main criteria for the diagnosis of BN are recurrent binges (the consumption of an unusually large amount of food within a short time interval associated with loss of control) associated with compensatory behaviours, including vomiting, excessive physical activity or fasting at least once a week for three months, and excessive preoccupation with shape and weight.<sup><xref ref-type="bibr" rid="bibr24-2045125318814734">24</xref>,<xref ref-type="bibr" rid="bibr25-2045125318814734">25</xref></sup> BED is characterized by the intermittent consumption of large quantities of food, with a sense of loss of control (binge eating), at least once a week for three months without the use of the extreme compensatory strategies, and the experience of marked distress regarding the binge eating; three or more of the following symptoms have to be present: eating more rapidly than normal, eating until feeling uncomfortably full, eating large amounts of food when not feeling physically hungry, eating alone because of being embarrassed by how much one is eating, and feeling disgusted with oneself, depressed, or very guilty after overeating.<sup><xref ref-type="bibr" rid="bibr24-2045125318814734">24</xref></sup></p>
<p>Given that transitions between diagnostic categories are common, some theorists have proposed dimensional models of EDs or, in other words, a spectrum of disordered eating. This view is supported by the fact that there are many overlapping risk factors and symptoms<sup><xref ref-type="bibr" rid="bibr25-2045125318814734">25</xref>,<xref ref-type="bibr" rid="bibr27-2045125318814734">27</xref>,<xref ref-type="bibr" rid="bibr28-2045125318814734">28</xref></sup> and by estimates of the genetic correlation between AN and BN, based on data derived from the Swedish Twin Study of Adults, which show that common comorbidity of AN and BN can in part be accounted for by shared genetic and environmental influences.<sup><xref ref-type="bibr" rid="bibr29-2045125318814734">29</xref></sup> Therefore, this review will not only include specific EDs, but will also include the main pathophysiological factors that may apply for the spectrum of EDs.</p>
</sec>
<sec id="section4-2045125318814734">
<title>Aim of this review</title>
<p>This review summarises the results of genetic research in order to develop a hypothetical pathophysiological model of EDs (<xref ref-type="fig" rid="fig1-2045125318814734">Figure 1</xref>). This hypothetical model will outline the wider picture of biological factors contributing to the development of EDs. As explained above, we have included microbiome studies in this review, as the importance of the microbiome for psychiatric disorders, and specifically for EDs, is increasingly acknowledged by researchers,<sup><xref ref-type="bibr" rid="bibr30-2045125318814734">30</xref><xref ref-type="bibr" rid="bibr31-2045125318814734"></xref><xref ref-type="bibr" rid="bibr32-2045125318814734"></xref><xref ref-type="bibr" rid="bibr33-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr34-2045125318814734">34</xref></sup> and the majority of microbiota research uses genetic methods. We do not aim to provide a detailed and comprehensive summary of genetic and microbiome research and their methods, as detailed summaries have already been written in previous years on genetic<sup><xref ref-type="bibr" rid="bibr35-2045125318814734">35</xref><xref ref-type="bibr" rid="bibr36-2045125318814734"></xref><xref ref-type="bibr" rid="bibr37-2045125318814734"></xref><xref ref-type="bibr" rid="bibr38-2045125318814734"></xref><xref ref-type="bibr" rid="bibr39-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr40-2045125318814734">40</xref></sup> and gut microbiota<sup><xref ref-type="bibr" rid="bibr34-2045125318814734">34</xref></sup> research in EDs.</p>
<fig id="fig1-2045125318814734" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Schematic and simplified depiction of a pathophysiological model of eating disorders based on genetic findings.</p>
<p>SCFAs, short chain fatty acids; LPS, lipopolysaccharides; GABA, gamma-aminobutyric acid; B ClpB, caseinolytic protease; EBF1, early B-cell factor 1; EPHX2, epoxide hydrolase 2; MHC, major histocompatibility complex; 5-HT, serotonin; DA, dopamine; CB, cannabinoid; Op, opioids; α-MSH, melanocyte-stimulating hormone.</p>
<p>For further details see section ‘A pathophysiological model of eating disorders based on genetic findings’.</p>
</caption>
<graphic xlink:href="10.1177_2045125318814734-fig1"></graphic>
</fig>
</sec>
</sec>
<sec id="section5-2045125318814734">
<title>Formal genetic studies</title>
<sec id="section6-2045125318814734">
<title>Family studies</title>
<p>The familial nature of AN has been well established; the first-degree relatives of individuals with AN have an approximately 10-fold greater lifetime risk of falling ill with an ED than relatives of unaffected individuals.<sup><xref ref-type="bibr" rid="bibr41-2045125318814734">41</xref><xref ref-type="bibr" rid="bibr42-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr43-2045125318814734">43</xref></sup> However, family studies are unable to determine the extent to which the observed familial aggregation is due to genetic or environmental factors.</p>
</sec>
<sec id="section7-2045125318814734">
<title>Twin studies</title>
<p>To determine the genetic risk, twin studies have been performed, which have yielded a high heritability of 50–60%; for example, a large twin study performed by Bulik and colleagues led to a heritability estimation for AN of 56%, with the remaining variance attributable to both shared and unique environment factors.<sup><xref ref-type="bibr" rid="bibr44-2045125318814734">44</xref></sup> Holland and colleagues showed concordance rates for AN of 0.71 for monozygotic twins and 0.1 for dizygotic twins.<sup><xref ref-type="bibr" rid="bibr45-2045125318814734">45</xref></sup></p>
<p>Twin studies also revealed that genetic effects and environmental factors contribute to the liability to BN.<sup><xref ref-type="bibr" rid="bibr36-2045125318814734">36</xref></sup> BN aggregates in families of affected patients. The relative risks for BN have been reported as 4.2 and 4.4 for first-degree female relatives of patients with AN and BN, respectively.<sup><xref ref-type="bibr" rid="bibr42-2045125318814734">42</xref></sup> Twin studies of BED have reported heritability estimates between 41% and 57%, depending on the criteria for BED.<sup><xref ref-type="bibr" rid="bibr46-2045125318814734">46</xref><xref ref-type="bibr" rid="bibr47-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr48-2045125318814734">48</xref></sup></p>
</sec>
<sec id="section8-2045125318814734">
<title>Adoption studies</title>
<p>To the best of our knowledge, adoption studies are lacking in EDs. However, in studies investigating disordered eating symptoms, an adoption study with 123 adopted and 56 biological female sibling pairs was published by Klump and colleagues.<sup><xref ref-type="bibr" rid="bibr49-2045125318814734">49</xref></sup> Eating pathology, body dissatisfaction, weight preoccupation and binge eating were assessed with the Minnesota Eating Behaviors Survey.<sup><xref ref-type="bibr" rid="bibr50-2045125318814734">50</xref></sup> Using biometric model fitting, the authors calculated significant genetic influences between 59% and 82% on all forms of disordered eating. Nonshared environmental factors accounted for the remaining variance. These data demonstrate the significant genetic effect on disordered eating.<sup><xref ref-type="bibr" rid="bibr49-2045125318814734">49</xref></sup></p>
</sec>
</sec>
<sec id="section9-2045125318814734">
<title>Molecular genetic studies</title>
<sec id="section10-2045125318814734">
<title>Linkage studies</title>
<p>Linkage studies aim to identify genomic regions that have an increased likelihood of containing genes that are associated with a disorder or trait. Genetic linkage means the tendency of DNA sequences to be inherited together, if they are located close together in the same region on a chromosome. A linkage analysis is conducted on samples of related individuals, including parent–offspring trios, affected sibling pairs or dense pedigrees. Linkage analyses in EDs have detected signals on chromosomes 1, 2, 3, 4 and 13 for AN and on chromosome 10 for BN.<sup><xref ref-type="bibr" rid="bibr39-2045125318814734">39</xref>,<xref ref-type="bibr" rid="bibr51-2045125318814734">51</xref><xref ref-type="bibr" rid="bibr52-2045125318814734"></xref><xref ref-type="bibr" rid="bibr53-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr54-2045125318814734">54</xref></sup> Fine mapping of one of these regions on chromosome 1 identified the serotonin 1D (HTR1D) and the opioid delta 1 receptor (OPRD1) genes.<sup><xref ref-type="bibr" rid="bibr52-2045125318814734">52</xref></sup> However, without subsequent fine mapping, a key limitation of linkage analysis is its inability to narrow down regions to an experimentally feasible number of genes.<sup><xref ref-type="bibr" rid="bibr40-2045125318814734">40</xref></sup></p>
</sec>
<sec id="section11-2045125318814734">
<title>Candidate–gene association studies</title>
<p>Candidate–gene association studies are hypothesis-driven evaluations of specific variants in a particular gene, most often selected on the basis of a biological hypothesis, as a candidate gene is a prespecified gene of interest that may be associated with a phenotype or disease state. Candidate–gene association studies have been most successful for diseases in which the relevance of the selected gene to the biology of the disorder was already well established.<sup><xref ref-type="bibr" rid="bibr55-2045125318814734">55</xref></sup> For example, candidate–gene studies have identified common and rare alleles in genes already known to influence serum lipid phenotypes, including levels of low-density lipoprotein and triglycerides.<sup><xref ref-type="bibr" rid="bibr56-2045125318814734">56</xref></sup> For psychiatric disorders in which the underlying biology remains fully elucidated, candidate–gene studies involve more speculation regarding the relevance of the selected gene and thus have a smaller prior probability of detecting a true association.<sup><xref ref-type="bibr" rid="bibr55-2045125318814734">55</xref></sup></p>
<sec id="section12-2045125318814734">
<title>Candidate–gene studies in anorexia nervosa</title>
<p>A systematic search for human genetic candidate–gene associations studies in AN found associations of AN with (a) genes related to neurotransmitters, including serotonin, norepinephrine and glutamate, (b) genes related to hunger regulatory systems, including leptin, agouti-related peptide (AGRP), melanocyte-stimulating hormone (α-MSH), the melanocortin-4 receptor (MC4R), neuropeptide Y (NPY) and ghrelin, (c) genes related to feeding motivation- and reward-related systems, including opioids, cannabinoids and dopamine, (d) genes related to systems regulating energy metabolism, (e) to neuroendocrine systems, and (f) to the immune system and inflammatory response.<sup><xref ref-type="bibr" rid="bibr57-2045125318814734">57</xref></sup> Overall, the studies summarized in this review examine only one or a few markers and have small samples. The majority of these results have not been replicated in larger samples, and these associations do not emerge in GWASs. Therefore, no far-reaching conclusions should be drawn on the basis of these results.</p>
</sec>
<sec id="section13-2045125318814734">
<title>Candidate–gene studies in bulimia nervosa</title>
<p>In BN, candidate–gene association studies revealed nonsignificant or conflicting results for the serotonin transporter, dopamine receptor D4, catechol-O-methyltransferase, leptin receptor, MC4R, AGRP, proopiomelanocortin (POMC), oestrogen receptor 1, and the brain-derived neurotrophic factor (BDNF) (for review see<sup><xref ref-type="bibr" rid="bibr40-2045125318814734">40</xref></sup>). Positive results were obtained in genetic studies investigating polymorphisms in ghrelin,<sup><xref ref-type="bibr" rid="bibr58-2045125318814734">58</xref></sup> oestrogen receptor ER<sub>2</sub>,<sup><xref ref-type="bibr" rid="bibr59-2045125318814734">59</xref></sup> cannabinoid receptor CR<sub>1</sub>,<sup><xref ref-type="bibr" rid="bibr60-2045125318814734">60</xref></sup> and the fat mass and obesity-associated gene.<sup><xref ref-type="bibr" rid="bibr61-2045125318814734">61</xref>,<xref ref-type="bibr" rid="bibr62-2045125318814734">62</xref></sup> However, none of these positive results have been independently replicated in larger samples.</p>
</sec>
<sec id="section14-2045125318814734">
<title>Candidate–gene studies in binge-eating disorder</title>
<p>In BED, candidate–gene association studies revealed nonsignificant or conflicting results for ankyrin repeat and kinase domain containing 1, ghrelin, MC4R, and BDNF genes (for review, see the work by Yilmaz et al.<sup><xref ref-type="bibr" rid="bibr40-2045125318814734">40</xref></sup>). Positive results were obtained in genetic studies investigating polymorphisms in the serotonin transporter,<sup><xref ref-type="bibr" rid="bibr60-2045125318814734">60</xref></sup> dopamine receptor D<sub>2</sub><sup><xref ref-type="bibr" rid="bibr63-2045125318814734">63</xref></sup> and μ<sub>1</sub>-opioid receptor.<sup><xref ref-type="bibr" rid="bibr64-2045125318814734">64</xref></sup> Similar to the positive results derived from candidate–gene studies in BN, none of these results have been replicated.</p>
</sec>
</sec>
<sec id="section15-2045125318814734">
<title>Genome-wide association studies</title>
<p>GWASs have evolved over the last 10 years into a useful tool for investigating the genetic architecture of human disease and can be described as the current workhorse of psychiatric genetics.<sup><xref ref-type="bibr" rid="bibr65-2045125318814734">65</xref></sup> A GWAS is an observational study of a genome-wide set of genetic variants in different individuals to determine whether any variant is associated with a trait. Like candidate–gene associations studies, GWASs compare cases and controls, but they investigate up to 1,000,000 genetic markers in hundreds of thousands of study participants using a hypothesis-free approach. As with the majority of psychiatric disorders, GWASs suggest that AN is polygenic in nature, with several genetic variants of small effect being involved.<sup><xref ref-type="bibr" rid="bibr66-2045125318814734">66</xref><xref ref-type="bibr" rid="bibr67-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr68-2045125318814734">68</xref></sup></p>
<p>In a GWAS comprising 12 cohorts (3495 AN cases and 10,982 controls), only one genome-wide significant locus on chromosome 12 in a region harbouring a previously reported type 1 diabetes and autoimmune disorder locus was identified.<sup><xref ref-type="bibr" rid="bibr68-2045125318814734">68</xref></sup> Multiple genes in the region around this top SNP rs4622308 reached gene-based significance. The top locus in this region and the fourth top locus in the SNP-based analyses of this study was FAM19A2, a putative chemokine or cytokine.<sup><xref ref-type="bibr" rid="bibr68-2045125318814734">68</xref></sup> Candidate genes from previous studies did not reach gene-based significance in this study (for further details see the work by Duncan et al.<sup><xref ref-type="bibr" rid="bibr68-2045125318814734">68</xref></sup>).</p>
<p>Li and colleagues published the results of a GWAS of 692 female AN cases and 3570 female matched controls. They conducted an analysis of phenotypic variability which led to the identification of a specific genetic risk factor that approached genome-wide significance. This SNP, rs929626, is located in the sixth intron of the early b-cell factor 1 (EBF1) gene which influences leptin signalling. Thus, the authors concluded that their finding suggests that a variant-mediated dysregulation of leptin signalling may be involved in the pathophysiology of AN.<sup><xref ref-type="bibr" rid="bibr69-2045125318814734">69</xref></sup> However, EBF1 is also important in the immune system for B-cell maturation.<sup><xref ref-type="bibr" rid="bibr70-2045125318814734">70</xref>,<xref ref-type="bibr" rid="bibr71-2045125318814734">71</xref></sup></p>
<p>The latest GWAS in AN based on 2158 cases from nine populations of European origin and 15,485 ancestrally matched controls was published by Huckins and colleagues and focused on common, low-frequency and rare genome-wide variation in AN.<sup><xref ref-type="bibr" rid="bibr72-2045125318814734">72</xref></sup> Although no results reached genome-wide significance, two notable common variants were identified. The first was an intronic variant associated with the OPCML gene that codes for an opioid-binding protein, which is localized in the plasma membrane and may have an accessory role in opioid receptor function. The second was an intergenic variant associated with the ANKRD50 gene, which is a protein-coding gene involved in the endosome-to-plasma membrane trafficking and recycling of cargo proteins, including glucose transporter 1 (GLUT1).<sup><xref ref-type="bibr" rid="bibr72-2045125318814734">72</xref>,<xref ref-type="bibr" rid="bibr73-2045125318814734">73</xref></sup></p>
<p>GWASs in EDs have been used to calculate genetic correlations between different disorders, or between disorders and physical traits. Significant positive genetic correlations were observed between AN and schizophrenia, obsessive–compulsive disorder (OCD), neuroticism, educational attainment, and high-density lipoprotein cholesterol. Significant negative genetic correlations were obtained between AN and body mass index (BMI), insulin sensitivity, glucose metabolism, and lipid phenotypes.<sup><xref ref-type="bibr" rid="bibr68-2045125318814734">68</xref>,<xref ref-type="bibr" rid="bibr74-2045125318814734">74</xref>,<xref ref-type="bibr" rid="bibr75-2045125318814734">75</xref></sup></p>
<p>Genetic studies using state-of-the-art technologies in BN or BED are limited and, to the best of our knowledge, no large GWASs have been performed in BN and BED. However, Wade and colleagues conducted a GWAS in 2564 female twins.<sup><xref ref-type="bibr" rid="bibr76-2045125318814734">76</xref></sup> They did not establish a diagnosis for BN or BED, although participants completed a health and lifestyle self-report questionnaire which included symptoms of disordered eating of the AN spectrum, BN spectrum and substance-induced purging. However, no association between symptoms of disordered eating and genetic variants reached genome-wide significance in this study. The authors concluded that larger samples and meta-analyses are required to identify genes and pathways contributing to predisposition to EDs.<sup><xref ref-type="bibr" rid="bibr76-2045125318814734">76</xref></sup></p>
<p>Although GWASs are considered an appropriate tool to identify genetic variants of genome-wide significance for the investigated disorder, the effect of certain genetic variants contributing to the overall heritability are too small to be detected by GWASs. This phenomenon is referred to as missing heritability, which should be taken into account while interpreting GWAS data.<sup><xref ref-type="bibr" rid="bibr77-2045125318814734">77</xref>,<xref ref-type="bibr" rid="bibr78-2045125318814734">78</xref></sup> Statisticians are currently developing solutions on how to combine such weak but possibly important signals to increase the power of GWASs.<sup><xref ref-type="bibr" rid="bibr77-2045125318814734">77</xref><xref ref-type="bibr" rid="bibr78-2045125318814734"></xref><xref ref-type="bibr" rid="bibr79-2045125318814734"></xref><xref ref-type="bibr" rid="bibr80-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr81-2045125318814734">81</xref></sup></p>
</sec>
</sec>
<sec id="section16-2045125318814734">
<title>Epigenetics</title>
<p>Epigenetics examines changes in gene function that do not involve changes in the DNA sequence.<sup><xref ref-type="bibr" rid="bibr82-2045125318814734">82</xref></sup> Epigenetic mechanisms include methylation of the DNA, histone modification, and the regulation of gene expression at the transcriptional and post-transcriptional level by noncoding ribonucleic acids (RNAs), including micro-RNAs (miRNAs), short-interfering RNAs (siRNAs), and piwi-interacting RNAs (piRNAs).<sup><xref ref-type="bibr" rid="bibr83-2045125318814734">83</xref></sup></p>
<sec id="section17-2045125318814734">
<title>Global methylation studies</title>
<p>The majority of epigenetic studies in EDs have measured the global DNA methylation level. Methylation can change the activity of a DNA segment without changing the sequence. When located in a gene promoter, DNA methylation typically acts to repress gene transcription. However, to measure global methylation means quantifying the 5-methylcytosine content across the whole DNA. This approach does not look at specific DNA segments or genes. Frieling and colleagues identified global DNA hypomethylation in patients with AN compared with controls.<sup><xref ref-type="bibr" rid="bibr84-2045125318814734">84</xref></sup> In this study, patients with AN showed a trend towards a lower global methylation compared with patients with BN, and no difference was found between patients with BN and controls. A reduction of global DNA methylation was also found in a trial performed by Tremolizzo and colleagues in adolescents with AN.<sup><xref ref-type="bibr" rid="bibr85-2045125318814734">85</xref></sup> However, no evidence for altered global DNA methylation in association with AN was found by Saffrey and colleagues,<sup><xref ref-type="bibr" rid="bibr86-2045125318814734">86</xref></sup> whereas increased global methylation in AN was reported by Booij and colleagues.<sup><xref ref-type="bibr" rid="bibr87-2045125318814734">87</xref></sup></p>
</sec>
<sec id="section18-2045125318814734">
<title>Epigenome-wide association studies</title>
<p>Epigenome-wide association studies allow for the determination of global DNA methylation and also to regional changes in DNA methylation throughout the genome. These studies can lead to epigenetic results relating to a specific gene. For example, the abovementioned study by Booij and colleagues<sup><xref ref-type="bibr" rid="bibr87-2045125318814734">87</xref></sup> measured not only global methylation, but also methylation of specific genes. In women with AN, they identified hypermethylated regions representing genes associated with histone acetylation, RNA modification, cholesterol storage and lipid transport, and dopamine and glutamate signalling. Of note, they specifically detected hypermethylated sites at the Tenascin XB (TNXB) gene.<sup><xref ref-type="bibr" rid="bibr87-2045125318814734">87</xref></sup> This result was confirmed by Kesselmeier and colleagues in a high-throughput DNA methylation analysis of blood from 47 females with AN, 47 lean females without AN and 100 controls.<sup><xref ref-type="bibr" rid="bibr88-2045125318814734">88</xref></sup> TNXB encodes an extracellular matrix glycoprotein with antiadhesive effects.<sup><xref ref-type="bibr" rid="bibr89-2045125318814734">89</xref></sup> Absence of this protein in humans has been associated with the Ehlers-Danlos syndrome, a connective tissue disorder.<sup><xref ref-type="bibr" rid="bibr90-2045125318814734">90</xref></sup> The gene is located on chromosome 6 within the major histocompatibility complex (MHC) class III region.<sup><xref ref-type="bibr" rid="bibr91-2045125318814734">91</xref></sup></p>
<p>Although the results of global methylation studies and epigenome-wide association studies are promising, it is important to take into account that the sample sizes of the reported studies are small and that epigenetic changes are tissue specific. Additionally, epigenetic changes are associated with diurnal and seasonal factors, medication, exercise, diseases, diet, psychological and socioeconomic factors.<sup><xref ref-type="bibr" rid="bibr92-2045125318814734">92</xref></sup> It may be the case that these factors account for the contradictory results obtained in the abovementioned global methylation studies.<sup><xref ref-type="bibr" rid="bibr84-2045125318814734">84</xref><xref ref-type="bibr" rid="bibr85-2045125318814734"></xref><xref ref-type="bibr" rid="bibr86-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr87-2045125318814734">87</xref></sup></p>
</sec>
</sec>
<sec id="section19-2045125318814734">
<title>Gene expression studies</title>
<p>Gene expression is the process by which genetic instructions, as they are coded on the DNA, are used to synthesize gene products such as messenger RNA (mRNA), functional RNA or proteins. To our knowledge, most of the gene expression studies in EDs measured mRNA expression.</p>
<sec id="section20-2045125318814734">
<title>Messenger ribonucleic acid expression studies</title>
<p>Changes in the mRNA expression have been reported in atrial natriuretic peptide (ANP),<sup><xref ref-type="bibr" rid="bibr93-2045125318814734">93</xref></sup> cannabinoid 1 receptor (CB1),<sup><xref ref-type="bibr" rid="bibr94-2045125318814734">94</xref></sup> POMC,<sup><xref ref-type="bibr" rid="bibr95-2045125318814734">95</xref></sup> and dopamine transporter (DAT) and D2 receptor (DRD2)<sup><xref ref-type="bibr" rid="bibr96-2045125318814734">96</xref></sup> genes in people with AN. Additionally, the expression of leptin receptor-coding gene was shown to differ significantly between binge–purge AN subtype and restricting subtype patients, and between AN restricting subtype patients and control participants.<sup><xref ref-type="bibr" rid="bibr97-2045125318814734">97</xref></sup> Kahl and colleagues observed an increase in mRNA expression of tumour necrosis factor (TNF)-α and interleukin (IL)-6 in patients with AN at hospital admission compared with controls. The mRNA expression of TNF-α remained significantly higher, whereas that of IL-6 decreased in weight-restored patients.<sup><xref ref-type="bibr" rid="bibr38-2045125318814734">38</xref>,<xref ref-type="bibr" rid="bibr98-2045125318814734">98</xref></sup></p>
</sec>
</sec>
<sec id="section21-2045125318814734">
<title>Gene–gene interaction studies</title>
<p>Genes do not function alone but exert effects on disease traits together with other genes (gene–gene interactions) and through interactions with environmental factors. Mercander and colleagues performed a family-based association study with 151 TagSNPs covering 10 neurotrophin signalling genes in 371 EDs trios of Spanish, French and German origin. They found that the nerve growth factor (NGFB) gene modified the AN risk conferred by certain neurotrophic receptor tyrosine kinase 3 (NTRK3)-risk genotypes by a synergistic gene–gene interaction.<sup><xref ref-type="bibr" rid="bibr99-2045125318814734">99</xref></sup></p>
<p>A study by Urwin and Nunn provided evidence for an important interaction between the monoamine oxidase A (MAOA) and serotonin transporter (SERT) genes.<sup><xref ref-type="bibr" rid="bibr100-2045125318814734">100</xref></sup> They assessed 114 patients with AN and their biological parents, and found that a SERT gene genotype with no apparent individual effect was preferentially transmitted to children with AN when the more active MAOA gene variant was also transmitted. In this study, the increased risk of developing the disorder was up to eight times greater than the risk imposed by the MAOA gene variant alone.<sup><xref ref-type="bibr" rid="bibr100-2045125318814734">100</xref></sup></p>
<p>Cui and colleagues combined linkage analyses and methods to examine gene–gene interactions.<sup><xref ref-type="bibr" rid="bibr101-2045125318814734">101</xref></sup> DNA was collected from two large families affected by EDs, and mutations segregating with illness were identified using a combination of microarray linkage and whole-genome sequencing. In the first family, linkage analysis of 20 members across three generations identified a rare missense mutation in the oestrogen-related receptor-α (ESRRA) gene that segregated with illness. In the second family, the analysis of eight members across four generations identified a missense mutation in the histone deacetylase 4 (HDAC4) gene that segregated with illness. The authors followed up on these findings with a transcriptional analysis. The HDAC4 transcript was found to repress the expression of ESRRA <italic>in vitro</italic> and in <italic>in vivo</italic> animal experiments.<sup><xref ref-type="bibr" rid="bibr101-2045125318814734">101</xref></sup></p>
</sec>
<sec id="section22-2045125318814734">
<title>Nutritional genomics</title>
<p>The science of nutritional genomics includes nutrigenetics and nutrigenomics. Nutrigenetic studies examine the effect of genetic variation on diet, and the response to certain nutrients. Nutrigenomic studies aim to assess the influence of nutrients on the expression of genes.<sup><xref ref-type="bibr" rid="bibr38-2045125318814734">38</xref>,<xref ref-type="bibr" rid="bibr102-2045125318814734">102</xref>,<xref ref-type="bibr" rid="bibr103-2045125318814734">103</xref></sup></p>
<sec id="section23-2045125318814734">
<title>Nutrigenetic studies</title>
<p>Nutrigenetic research in EDs remains in its infancy. However, the first studies have revealed promising results. For example, Scott-Van Zeeland and colleagues reported gene variants within the epoxide hydrolase 2 (EPHX2) gene were associated with susceptibility to AN,<sup><xref ref-type="bibr" rid="bibr104-2045125318814734">104</xref></sup> and data from the same study group showed that, on eating a meal, an increase of pro-inflammatory molecules was observed in AN patients, but not in healthy controls, depending on EPHX2 enzyme activity and the consumed polyunsaturated fatty acids (PUFAs).<sup><xref ref-type="bibr" rid="bibr105-2045125318814734">105</xref></sup> An EPHX2-dependent inflammatory response following a meal in those with AN, but not in healthy controls, suggests that the genetically determined way our body reacts to certain nutrients may contribute to the development of an ED.</p>
</sec>
<sec id="section24-2045125318814734">
<title>Nutrigenomic studies</title>
<p>The general aim of nutrigenomics is to identify the effects of nutrients, including macronutrients and micronutrients, on the genome.<sup><xref ref-type="bibr" rid="bibr103-2045125318814734">103</xref></sup> However, nutrigenomic studies, including studies in other genetic subdisciplines, require large sample sizes to identify those interactions and to reveal fundamental biological insights.<sup><xref ref-type="bibr" rid="bibr38-2045125318814734">38</xref>,<xref ref-type="bibr" rid="bibr16-2045125318814734">16</xref></sup> Although nutrigenomic studies may offer a promising approach to elucidate the effects of diet on health, to the best our knowledge, no such nutrigenomic studies have been performed in the field of EDs in order to determine the influence of dietary ingredients on the genome.</p>
</sec>
</sec>
<sec id="section25-2045125318814734">
<title>Genetics of the microbiome</title>
<p>In microbiome studies, stool samples are usually collected from study participants, and the bacterial DNA is extracted and determined using commercially available kits.</p>
<p>Gut microbiota has been demonstrated as involved in different metabolic functions, including the regulation of weight gain, energy harvest from the diet and insulin secretion, and is heavily influenced by diet and lifestyle.<sup><xref ref-type="bibr" rid="bibr33-2045125318814734">33</xref>,<xref ref-type="bibr" rid="bibr106-2045125318814734">106</xref></sup></p>
<p>The microbiota are reported to produce an array of bioactive metabolic products capable of entering the systemic circulation. These metabolic products can have profound effects on host metabolism, immune function, and gene expression in several organ systems, including the central nervous system (CNS).<sup><xref ref-type="bibr" rid="bibr107-2045125318814734">107</xref></sup> Short chain fatty acids (SCFAs) are volatile fatty acids produced by bacteria in the bowel. Acetic acid, propionic acid, and butyric acid are the most abundant.<sup><xref ref-type="bibr" rid="bibr108-2045125318814734">108</xref></sup> Butyrate is rapidly used as an energy source for colonocytes, whereas the majority of acetate and propionate enter the portal circulation.<sup><xref ref-type="bibr" rid="bibr109-2045125318814734">109</xref></sup> Butyrate is an HDAC inhibitor with potential effects on gene expression in human cells.<sup><xref ref-type="bibr" rid="bibr110-2045125318814734">110</xref></sup> Propionate crosses the blood–brain barrier, enters the CNS and affects various physiological processes, including cell signalling, neurotransmitter synthesis and release, free-radical production and mitochondrial function. Propionate is a precursor for cholesterol synthesis regulation and gluconeogenesis in the liver.<sup><xref ref-type="bibr" rid="bibr111-2045125318814734">111</xref></sup> Acetate is the main SCFA in the blood and has a key metabolic role in peripheral tissues where it acts as a substrate for lipogenesis.<sup><xref ref-type="bibr" rid="bibr31-2045125318814734">31</xref>,<xref ref-type="bibr" rid="bibr112-2045125318814734">112</xref></sup> Therefore, microbiota are capable of modulating the brain and the metabolic system of the body.</p>
<p>Enteroendocrine cells express specific receptors for bacterial products, and these cells modify the secretion of hormones that regulate hunger and satiety according to the obtained receptor signals.<sup><xref ref-type="bibr" rid="bibr113-2045125318814734">113</xref></sup> Additionally, bacterial products, including lipopolysaccharides (LPS) modulate the function of the blood–brain barrier and increase its permeability, thus increasing the effect of circulating cytokines to appetite regulation.<sup><xref ref-type="bibr" rid="bibr114-2045125318814734">114</xref></sup> Furthermore, the host produces antibodies against microbial peptides, which can act as autoantibodies against appetite-regulating hormones including α-MSH.<sup><xref ref-type="bibr" rid="bibr115-2045125318814734">115</xref><xref ref-type="bibr" rid="bibr116-2045125318814734"></xref><xref ref-type="bibr" rid="bibr117-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr118-2045125318814734">118</xref></sup> Therefore, it can be concluded that the microbiota can influence major processes within the immune system.</p>
<p>However, literature in this area remains limited, with only a small number of studies measuring gut bacterial profiles in patients with EDs.<sup><xref ref-type="bibr" rid="bibr112-2045125318814734">112</xref>,<xref ref-type="bibr" rid="bibr118-2045125318814734">118</xref><xref ref-type="bibr" rid="bibr119-2045125318814734"></xref><xref ref-type="bibr" rid="bibr120-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr121-2045125318814734">121</xref></sup> These studies identified novel bacterial species in patients with AN admitted to hospital,<sup><xref ref-type="bibr" rid="bibr112-2045125318814734">112</xref></sup> profound microbial perturbations in patients with AN compared with controls, and disturbed SCFA profiles in patients with AN.<sup><xref ref-type="bibr" rid="bibr30-2045125318814734">30</xref><xref ref-type="bibr" rid="bibr31-2045125318814734"></xref><xref ref-type="bibr" rid="bibr32-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr33-2045125318814734">33</xref></sup></p>
<p>In addition to SCFAs, there are other molecules produced by human microbiota that may influence the brain, in addition to appetite and weight regulation. For example, caseinolytic protease B (ClpB) produced by enterobacteria has been identified as a mimetic of α-MSH. In a study by Breton and colleagues, plasma concentrations of ClpB were measured in female patients with AN, BN, and BED, and were compared with healthy participants. ClpB concentrations were elevated in patients with ED, without significant differences in patient subgroups. Plasma ClpB concentrations correlated with ED psychopathology and α-MSH. These results suggest a link between bacterial ClpB and the ED pathophysiology.<sup><xref ref-type="bibr" rid="bibr121-2045125318814734">121</xref></sup></p>
<p>In this context, it is important to refer to a study that examined the use of antimicrobial medication in a large patient cohort treated for BED, BN, and AN over the 5-year period preceding ED treatment. A total of 1592 patients with an ED were compared with 6368 matched controls from the general population. The study population was linked to the prescription data of antibacterial, antifungal and antiviral medication. Individuals with BN and BED had received antimicrobial medication prescriptions more often than their matched controls, whereas no significant difference was found in AN. Regarding the defined daily doses per individual, patients with BN, BED, and males with AN had significantly higher total antimicrobial medication use. It was concluded that changes in intestinal microbiota due to infections, inflammation, or antibacterial medications may contribute to EDs.<sup><xref ref-type="bibr" rid="bibr122-2045125318814734">122</xref></sup></p>
</sec>
<sec id="section26-2045125318814734">
<title>A pathophysiological model of eating disorders based on genetic and gut microbiome findings</title>
<p>Family studies, twin studies and GWASs all suggest that genetics plays a major role in the development of EDs. In order to create a pathophysiological model based on the results of genetic studies, we have rearranged the findings to include factors outside the human body, the biology of the body which is significantly influenced by genes, and the resulting ED phenotype (<xref ref-type="fig" rid="fig1-2045125318814734">Figure 1</xref>). Significant nongenetic risk factors contributing to the aetiopathogenesis of EDs will be mentioned, but not explained in detail, as they are not the focus of this review. The reader may refer to the cited literature.</p>
<sec id="section27-2045125318814734">
<title>Factors outside the body</title>
<p>Relevant factors in the development of an ED from outside the body include the social environment, the biological environment and nutritional factors. Within the social environment, the socioeconomic status, culture and lifestyle, a certain ideal of beauty, relationships, and psychosocial stresses including academic challenges, which can have an impact on the emergence of an ED.<sup><xref ref-type="bibr" rid="bibr123-2045125318814734">123</xref>,<xref ref-type="bibr" rid="bibr124-2045125318814734">124</xref></sup> Additional relevant factors outside the human body mutually influencing each other include the biological environment, diet, and the use of medication and probiotics.<sup><xref ref-type="bibr" rid="bibr125-2045125318814734">125</xref><xref ref-type="bibr" rid="bibr126-2045125318814734"></xref><xref ref-type="bibr" rid="bibr127-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr128-2045125318814734">128</xref></sup></p>
<p>The above environmental factors are able to directly precede ED symptoms, for example, when a teenage girl does not fit the beauty ideal of her peers, is bullied for having ‘fat thighs’ and starts a diet, they can develop symptoms of AN, as it has been shown that bullying can lead to dieting, which is a major risk factor for the development of an ED.<sup><xref ref-type="bibr" rid="bibr129-2045125318814734">129</xref>,<xref ref-type="bibr" rid="bibr130-2045125318814734">130</xref></sup> These factors may also indirectly lead to an ED by influencing the biology of the body. For example, several cases have been reported in the literature, where streptococcus infection triggered an autoimmune response in the body that lead to AN.<sup><xref ref-type="bibr" rid="bibr131-2045125318814734">131</xref></sup></p>
</sec>
<sec id="section28-2045125318814734">
<title>Biological factors within the body</title>
<p>As described in the previous sections of this article, the most important elements of the biology of the human body for the development of an ED from a genetic perspective include the microbiome, the metabolic system, the immune system and the brain (middle of <xref ref-type="fig" rid="fig1-2045125318814734">Figure 1</xref>).</p>
<sec id="section29-2045125318814734">
<title>Microbiota</title>
<p>It has been hypothesized that microbes in the gastrointestinal tract manipulate their host’s eating behaviour to increase microbe fitness. Microbes may do this through generating cravings for foods that they specialize on or foods that suppress their competitors, or inducing dysphoria until individuals eat foods for the benefit of the microbes in their body.<sup><xref ref-type="bibr" rid="bibr115-2045125318814734">115</xref></sup> Such nutritional and environmental factors can lead to dysbiosis of the microbiome, which, as a consequence, alters the production of SCFAs, including acetic, propionic and butyric acid (an HDAC inhibitor),<sup><xref ref-type="bibr" rid="bibr110-2045125318814734">110</xref></sup> and of certain enzymes, including ClpB (a mimetic of α-MSH).<sup><xref ref-type="bibr" rid="bibr121-2045125318814734">121</xref></sup> As explained previously, the bacteria and the molecules they produce influence the metabolic system, the immune system, and the brain.<sup><xref ref-type="bibr" rid="bibr30-2045125318814734">30</xref><xref ref-type="bibr" rid="bibr31-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr32-2045125318814734">32</xref>,<xref ref-type="bibr" rid="bibr106-2045125318814734">106</xref><xref ref-type="bibr" rid="bibr107-2045125318814734"></xref><xref ref-type="bibr" rid="bibr108-2045125318814734"></xref><xref ref-type="bibr" rid="bibr1-2045125318814734"></xref><xref ref-type="bibr" rid="bibr1-2045125318814734"></xref><xref ref-type="bibr" rid="bibr1-2045125318814734"></xref><xref ref-type="bibr" rid="bibr109-2045125318814734"></xref><xref ref-type="bibr" rid="bibr110-2045125318814734"></xref><xref ref-type="bibr" rid="bibr111-2045125318814734"></xref><xref ref-type="bibr" rid="bibr112-2045125318814734"></xref><xref ref-type="bibr" rid="bibr113-2045125318814734"></xref><xref ref-type="bibr" rid="bibr114-2045125318814734"></xref><xref ref-type="bibr" rid="bibr115-2045125318814734"></xref><xref ref-type="bibr" rid="bibr116-2045125318814734"></xref><xref ref-type="bibr" rid="bibr117-2045125318814734"></xref><xref ref-type="bibr" rid="bibr118-2045125318814734"></xref><xref ref-type="bibr" rid="bibr119-2045125318814734"></xref><xref ref-type="bibr" rid="bibr120-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr121-2045125318814734">121</xref></sup></p>
</sec>
<sec id="section30-2045125318814734">
<title>Metabolic and endocrine system</title>
<p>The metabolic system comprises a number of metabolic and endocrine organs, including the gastrointestinal tract, the liver, endocrine glands, including the pancreas and the thyroid, and the fatty tissue, in addition to certain cell functions, including the transport of glucose into the cell. This system is influenced by food intake, diet, medication, physical activity, the homeostatic system of the brain and the immune system. It can alter the metabolism of cholesterol and lipids, and can send various hormonal signals, including ghrelin, insulin and leptin, to the brain and the immune system.<sup><xref ref-type="bibr" rid="bibr58-2045125318814734">58</xref>,<xref ref-type="bibr" rid="bibr97-2045125318814734">97</xref>,<xref ref-type="bibr" rid="bibr132-2045125318814734">132</xref></sup> The findings of associations between a variant of the ANKRD50 gene with AN and polymorphisms in the ghrelin<sup><xref ref-type="bibr" rid="bibr58-2045125318814734">58</xref></sup> and the fat mass and obesity-associated genes<sup><xref ref-type="bibr" rid="bibr61-2045125318814734">61</xref>,<xref ref-type="bibr" rid="bibr62-2045125318814734">62</xref></sup> with BN indicate the importance of the metabolic and endocrine system in the development of AN and BN from a genetic perspective.<sup><xref ref-type="bibr" rid="bibr72-2045125318814734">72</xref>,<xref ref-type="bibr" rid="bibr73-2045125318814734">73</xref></sup></p>
</sec>
<sec id="section31-2045125318814734">
<title>Immune system</title>
<p>The immune system reacts to stress, food intake, components of bacteria (LPS) or molecules produced by microbiota by altering its production of cytokines, including TNF-α and IL-6, chemokines and factors of cell differentiation, which have an influence on the brain.<sup><xref ref-type="bibr" rid="bibr105-2045125318814734">105</xref>,<xref ref-type="bibr" rid="bibr98-2045125318814734">98</xref>,<xref ref-type="bibr" rid="bibr133-2045125318814734">133</xref><xref ref-type="bibr" rid="bibr134-2045125318814734"></xref><xref ref-type="bibr" rid="bibr135-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr136-2045125318814734">136</xref></sup> EPHX2 enzyme activity has been demonstrated having a diet-dependent modulating influence on cytokine production.<sup><xref ref-type="bibr" rid="bibr104-2045125318814734">104</xref></sup> The fact that epigenetic research has identified a hypermethylated region at the TNXB gene, which is localized within the MHC class III region, is a further indication for the importance of the immune system.<sup><xref ref-type="bibr" rid="bibr87-2045125318814734">87</xref>,<xref ref-type="bibr" rid="bibr88-2045125318814734">88</xref>,<xref ref-type="bibr" rid="bibr91-2045125318814734">91</xref></sup> The MHC class III molecules include several proteins with immune functions, including cytokines. These proteins are involved in global and specific inflammatory responses.<sup><xref ref-type="bibr" rid="bibr137-2045125318814734">137</xref></sup> In this respect, it is interesting to mention that the strongest genetic association in schizophrenia at the population level involves variation in the MHC locus.<sup><xref ref-type="bibr" rid="bibr138-2045125318814734">138</xref></sup></p>
<p>In order to understand the possible significance of the immune system in the pathophysiology of EDs as indicated by genetic research, it is important to include the ways in which the immune system has been shown to influence other bodily systems, including the brain and the metabolic system. For example, in accordance with Kahl and colleagues, who observed an increase in the mRNA expression of TNF-α and IL-6 in patients with AN,<sup><xref ref-type="bibr" rid="bibr98-2045125318814734">98</xref></sup> meta-analyses have found elevated levels of TNF-α, IL-1 and IL-6 in patients with AN.<sup><xref ref-type="bibr" rid="bibr139-2045125318814734">139</xref>,<xref ref-type="bibr" rid="bibr140-2045125318814734">140</xref></sup> These changes may appear as a consequence of acute, chronic or social stress.<sup><xref ref-type="bibr" rid="bibr135-2045125318814734">135</xref>,<xref ref-type="bibr" rid="bibr136-2045125318814734">136</xref>,<xref ref-type="bibr" rid="bibr141-2045125318814734">141</xref></sup> Additionally, bacteria from the gut microbiota can stimulate the production of cytokines, for example by the release of LPS, which binds to pattern recognition receptors including Toll-like receptor 4, on circulating monocytes and macrophages.<sup><xref ref-type="bibr" rid="bibr142-2045125318814734">142</xref></sup> In turn, cytokines can influence the signal transduction of afferent nerves, including the vagus nerve, which convey information to the brain; they are also capable of permeating the blood–brain barrier, and influencing brain metabolism and signal processing by activating monoamine reuptake, stimulating the hypothalamic–pituitary–adrenocortical (HPA) axis and decreasing the production of serotonin <italic>via</italic> the increased activity of indolamine-2,3-dioxygenase.<sup><xref ref-type="bibr" rid="bibr133-2045125318814734">133</xref>,<xref ref-type="bibr" rid="bibr134-2045125318814734">134</xref></sup> The importance of the interplay between the immune system and the brain is further underlined by the fact that changes in the concentrations of pro-inflammatory cytokines have been found in the serum or plasma of patients with different psychiatric disorders, including depression,<sup><xref ref-type="bibr" rid="bibr134-2045125318814734">134</xref>,<xref ref-type="bibr" rid="bibr143-2045125318814734">143</xref></sup> post-traumatic stress disorder and schizophrenia.<sup><xref ref-type="bibr" rid="bibr144-2045125318814734">144</xref><xref ref-type="bibr" rid="bibr145-2045125318814734"></xref><xref ref-type="bibr" rid="bibr145-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr147-2045125318814734">147</xref></sup></p>
<p>The immune system is also closely linked to the metabolic and endocrine systems. Cytokines, including TNF-α, which are released during infection and inflammation, activate the HPA system at the hypothalamic, pituitary, and adrenal level, resulting in the release of cortisol as the most important negative feedback signal to prevent an overshoot of the ongoing host defence;<sup><xref ref-type="bibr" rid="bibr148-2045125318814734">148</xref><xref ref-type="bibr" rid="bibr149-2045125318814734"></xref><xref ref-type="bibr" rid="bibr150-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr151-2045125318814734">151</xref></sup> glucocorticoids, in turn, suppress the production of pro-inflammatory cytokines, and a chronically activated HPA axis in chronic stress results in defective immune system responses to an inflammatory challenge.<sup><xref ref-type="bibr" rid="bibr151-2045125318814734">151</xref><xref ref-type="bibr" rid="bibr152-2045125318814734"></xref><xref ref-type="bibr" rid="bibr153-2045125318814734"></xref><xref ref-type="bibr" rid="bibr154-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr155-2045125318814734">155</xref></sup> These interactions may partly explain the influence exerted by HPA axis hormones on natural killer cell (NK) activity in patients with AN.<sup><xref ref-type="bibr" rid="bibr156-2045125318814734">156</xref></sup> Similar to depression, a disturbed interplay between cytokines and the HPA axis has been found in AN.<sup><xref ref-type="bibr" rid="bibr151-2045125318814734">151</xref>,<xref ref-type="bibr" rid="bibr157-2045125318814734">157</xref></sup></p>
</sec>
<sec id="section32-2045125318814734">
<title>Brain</title>
<p>In order to sort and interpret genetic findings on the brain and neurotransmitter systems, we refer to an approach based on brain-imaging studies, which illustrates the importance of three specific brain systems for EDs: the self-regulatory, the hedonic and the homeostatic systems.<sup><xref ref-type="bibr" rid="bibr25-2045125318814734">25</xref></sup> In this approach, the self-regulatory system is located mainly in the prefrontal areas, which embeds eating into the social context, creates individual values and provides self-regulatory control in response to environmental, social and cultural factors. Important transmitters of this system are serotonin, noradrenalin, acetylcholine and glutamate, of which serotonin and glutamate have support from genetic studies. The hedonic system consists of regions in the prefrontal cortex, the basal ganglia and the thalamus. It is relevant for increasing the desire to eat and pleasure during food consumption on the basis of information from the sensory organs and the hippocampus using dopamine, opioids, and cannabinoids, which have been identified in genetic research of EDs, as neurotransmitters. The hypothalamic homeostatic system integrates peripheral signals of food consumption and energy storages, including leptin, in order to regulate appetite. α-MSH, of which POMC is a precursor protein and has been shown to be of importance in the development of AN in gene-expression studies, is an important signalling molecule of the homeostatic system.<sup><xref ref-type="bibr" rid="bibr25-2045125318814734">25</xref></sup></p>
<p>Genetic findings can be sorted according to these three brain systems. According to this classification, genetically predisposed alterations in brain function can be found in patients with an ED in the self-regulatory system, including modified serotonin signalling in patients with AN and BED,<sup><xref ref-type="bibr" rid="bibr39-2045125318814734">39</xref>,<xref ref-type="bibr" rid="bibr40-2045125318814734">40</xref>,<xref ref-type="bibr" rid="bibr53-2045125318814734">53</xref>,<xref ref-type="bibr" rid="bibr60-2045125318814734">60</xref>,<xref ref-type="bibr" rid="bibr81-2045125318814734">81</xref>,<xref ref-type="bibr" rid="bibr100-2045125318814734">100</xref></sup> and altered norepinephrine and glutamate signalling in patients with AN.<sup><xref ref-type="bibr" rid="bibr57-2045125318814734">57</xref></sup> Regarding the hedonic system, positive significant associations in AN, BN and BED have been found for dopamine, cannabinoid and opioid signalling.<sup><xref ref-type="bibr" rid="bibr60-2045125318814734">60</xref>,<xref ref-type="bibr" rid="bibr63-2045125318814734">63</xref>,<xref ref-type="bibr" rid="bibr64-2045125318814734">64</xref>,<xref ref-type="bibr" rid="bibr72-2045125318814734">72</xref>,<xref ref-type="bibr" rid="bibr94-2045125318814734">94</xref><xref ref-type="bibr" rid="bibr95-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr96-2045125318814734">96</xref></sup> The importance of the homeostatic system is demonstrated by associations of candidate genes in studies of patients with AN, in which genes associated with AGRP, α-MSH, MC4R, NPY appeared to be significantly associated;<sup><xref ref-type="bibr" rid="bibr57-2045125318814734">57</xref></sup> and in patients with BN, where positive results have been obtained for ghrelin,<sup><xref ref-type="bibr" rid="bibr58-2045125318814734">58</xref></sup> which unfolds its orexigenic effects in the hypothalamus.<sup><xref ref-type="bibr" rid="bibr132-2045125318814734">132</xref></sup> α-MSH signalling seems to be of specific importance, as this molecule is also relevant in the crosstalk between the microbiome and the brain.<sup><xref ref-type="bibr" rid="bibr115-2045125318814734">115</xref><xref ref-type="bibr" rid="bibr116-2045125318814734"></xref><xref ref-type="bibr" rid="bibr117-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr118-2045125318814734">118</xref></sup></p>
</sec>
</sec>
<sec id="section33-2045125318814734">
<title>Eating disorder phenotype</title>
<p>The combination of the biological processes which are influenced by environmental and nutritional factors lead to the behavioural traits of EDs, including an altered response to food intake due to inflammatory processes, to changes in the regulation of weight and metabolism, or an altered motivation towards food intake and physical activity. In EDs, however, the phenotype is not only defined by the psychological and behavioural symptoms of the disorder, but also by its consequence, for example, in the case of AN, malnutrition and an impairment of organ structure and function<sup><xref ref-type="bibr" rid="bibr26-2045125318814734">26</xref></sup> and thus, again, influencing the biology of the human body. EDs also put a strain on the patients’ relationships and lead to social withdrawal.<sup><xref ref-type="bibr" rid="bibr158-2045125318814734">158</xref></sup></p>
<p>Taken together, <xref ref-type="fig" rid="fig1-2045125318814734">Figure 1</xref> shows the major factors of the aetiopathogenesis EDs. These factors are related to the environment, nutrition, microbiota, regulatory systems of the body and ED symptoms, and they influence each other. The depicted information might assist in interpreting genetic findings regarding the microbiota and the human genome against the background of environmental and biological factors and the different facets of the ED phenotype.</p>
</sec>
</sec>
<sec id="section34-2045125318814734" sec-type="discussion">
<title>Discussion</title>
<sec id="section35-2045125318814734">
<title>The pathophysiological model</title>
<p>Even though the contemporary genetic knowledge regarding EDs has not led to specific diagnostic methods or therapies, it contributes to valuable novel insights into the pathophysiology of EDs and assists in interpreting findings from other research areas, including brain imaging, neuroimmunological and neuroendocrine research, psychopharmacology, and neuropsychology. On the basis of the reviewed literature, we propose a biological disease model based first and foremost on contemporary genetic findings and research on the microbiome. Although this model explains the connection between environmental and nutritional factors, microbiota and the metabolic system, the immune system, the CNS, and ED pathology, it has shortcomings due to uncertainties in the genetic knowledge and due to assumptions made regarding the nature of EDs.</p>
</sec>
<sec id="section36-2045125318814734">
<title>Shortcomings</title>
<p>Shortcomings in the genetic knowledge of EDs arise from the lack of certain types of genetic studies. For example, in other psychiatric disciplines, brain-imaging studies have revealed genetic effects on brain structure and function, thus implicating neural pathways and causal mechanisms.<sup><xref ref-type="bibr" rid="bibr159-2045125318814734">159</xref></sup> Despite substantial progress in neuroimaging studies,<sup><xref ref-type="bibr" rid="bibr160-2045125318814734">160</xref>,<xref ref-type="bibr" rid="bibr161-2045125318814734">161</xref></sup> published imaging genetic studies on EDs are limited. However, within the Enhancing Neuro Imaging Genetics by Meta-Analysis (ENIGMA) Consortium, there is an ENIGMA–AN imaging genetics working group dedicated to improving the understanding of structural brain changes in patients with AN.<sup><xref ref-type="bibr" rid="bibr162-2045125318814734">162</xref></sup></p>
<p>The same is unfortunately the case for pharmacogenetic studies, which may partly be due to a lack of consensus on effective pharmacological treatment strategies.<sup><xref ref-type="bibr" rid="bibr25-2045125318814734">25</xref></sup> Other areas of research lacking in EDs include the examination of common and rare variations, copy number variation, cross-disorder analysis, and gene-environment interplay, specifically the interplay between gene expression, genetic imprinting, and pre- and postnatal environmental factors.</p>
<p>The majority of genetic studies in EDs have been performed in AN, with only a limited number of studies in BN or BED. For example, no GWAS has been published for BN or BED, with the exception of symptoms of the BN spectrum.<sup><xref ref-type="bibr" rid="bibr67-2045125318814734">67</xref></sup> The reported GWASs in AN<sup><xref ref-type="bibr" rid="bibr67-2045125318814734">67</xref><xref ref-type="bibr" rid="bibr68-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr69-2045125318814734">69</xref>,<xref ref-type="bibr" rid="bibr72-2045125318814734">72</xref></sup> remain limited in their power to identify a meaningful set of genes contributing to AN, as one single significant locus in a study of thousands of patients with AN is a small outcome for such a large effort.</p>
<p>In addition, ED entities remain an area of discussion.<sup><xref ref-type="bibr" rid="bibr27-2045125318814734">27</xref>,<xref ref-type="bibr" rid="bibr28-2045125318814734">28</xref></sup> For example, AN may not be a purely psychiatric disorder, but a disorder with significant psychological, brain–anatomical, metabolic or immunological aspects. It may be the case that these traits will assist in subclassifying AN in the future. However, as highlighted in our explanations relating to <xref ref-type="fig" rid="fig1-2045125318814734">Figure 1</xref>, these systems are so closely linked together, that such subclassification may not work in practice.</p>
</sec>
<sec id="section37-2045125318814734">
<title>Current efforts for genetic research in EDs</title>
<p>Currently, the PGC is performing GWASs in EDs. It is the largest consortium in the history of psychiatry and has recently commenced a programme of research designed to deliver ‘actionable’ findings, with genomic results that reveal fundamental biology, inform clinical practice, and deliver novel therapeutic targets. The central idea of the PGC is to convert genetic findings into biologically, clinically, and therapeutically meaningful insights.<sup><xref ref-type="bibr" rid="bibr16-2045125318814734">16</xref></sup></p>
<p>Examples of promising contemporary studies collecting genetic data include the Avon Longitudinal Study of Parents and Children (ALSPAC), the Norwegian Mother and Child Cohort Study (MoBa), the Anorexia Nervosa Genetics Initiative (ANGI), the Charlotte’s Helix Project, the Binge Eating Genetics INitiative (BEGIN), and the abovementioned ENIGMA–AN work group. The ALSPAC is a prospective pregnancy cohort (baseline 1991–1992) charting the health of 14,500 families in the Bristol area.<sup><xref ref-type="bibr" rid="bibr163-2045125318814734">163</xref></sup> MoBa is a study for which &gt;90,000 pregnant women were recruited between 1998 and 2008, and in which &gt;70,000 of fathers participated.<sup><xref ref-type="bibr" rid="bibr164-2045125318814734">164</xref></sup> ANGI is the largest and most rigorous genetic investigation of EDs conducted to date. This international collaboration collected blood samples and clinical information from 13,364 individuals with lifetime AN as well as ancestrally matched controls. ANGI has thus substantially augmented the PGC AN sample collection. ANGI recruited from the United States, Australia, New Zealand, Sweden and Denmark <italic>via</italic> national registers, treatment centres, social and traditional media.<sup><xref ref-type="bibr" rid="bibr165-2045125318814734">165</xref></sup> The Charlotte’s Helix Project was founded in the UK to honour the ED advocacy work of Charlotte Bevan and is part of a global effort to collect DNA samples from &gt;25,000 individuals with AN.<sup><xref ref-type="bibr" rid="bibr166-2045125318814734">166</xref></sup> BEGIN will conduct a large GWAS in 2500 individuals with binge-type ED and matched controls, coupled with microbiota sampling, and deep phenotyping using an ED recovery application programmed on Apple watches.<sup><xref ref-type="bibr" rid="bibr167-2045125318814734">167</xref></sup></p>
<p>The sample sizes, phenotyping and statistical approaches of these initiatives are promising, and these projects are likely to elucidate further important pathophysiological factors leading to the development of EDs.</p>
</sec>
<sec id="section38-2045125318814734">
<title>Historical and philosophical considerations</title>
<p>It can be argued that heritability has already been considered in biblical times and that we are still unable to transform this relatively old idea into an effective therapy for patients, however, there is legitimate hope that novel genetic methods, including GWASs, will reveal crucial pathophysiological pathways for EDs and lead to novel therapeutic strategies in the near future.</p>
<p>Publication bias is widespread in biomedical research, including genetics.<sup><xref ref-type="bibr" rid="bibr168-2045125318814734">168</xref>,<xref ref-type="bibr" rid="bibr169-2045125318814734">169</xref></sup> The study by Rüdin<sup><xref ref-type="bibr" rid="bibr9-2045125318814734">9</xref></sup> was mentioned as a historic example of unpublished negative results in order not to challenge one’s political beliefs and risk one’s own carrier.<sup><xref ref-type="bibr" rid="bibr9-2045125318814734">9</xref></sup> Publication bias was not only a problem during the time of Nazi pervasion, it is an ongoing issue.<sup><xref ref-type="bibr" rid="bibr170-2045125318814734">170</xref></sup></p>
<p>The discovery of the unconscious and the development of antidepressants were significant breakthroughs in psychiatry, which had a marked impact not only on psychiatric treatment, but also on the way we see ourselves.<sup><xref ref-type="bibr" rid="bibr171-2045125318814734">171</xref>,<xref ref-type="bibr" rid="bibr172-2045125318814734">172</xref></sup> The elucidation that the microbiome has a significant impact on us may have a similar implication, as it shows that we are not a single entity, but more symbiosis of billions of organisms.</p>
</sec>
<sec id="section39-2045125318814734">
<title>Therapeutic implications</title>
<p>It may be the case that important discoveries have already been made, but we cannot realise them, in a manner similar to Gregor Johann Mendel, who gained recognition as the founder of formal genetics only posthumously. For example, the increase in the mRNA expression of TNF-α in patients with AN<sup><xref ref-type="bibr" rid="bibr98-2045125318814734">98</xref></sup> may have an impact on the development of novel drug targets for EDs as available anti-TNF-α drugs, for example etanercept, have been used in other psychiatric disorders and may, in principle, be assessed in EDs also.<sup><xref ref-type="bibr" rid="bibr173-2045125318814734">173</xref></sup></p>
<p>In addition to TNF-α and IL-6,<sup><xref ref-type="bibr" rid="bibr98-2045125318814734">98</xref></sup> we have discussed LPS,<sup><xref ref-type="bibr" rid="bibr114-2045125318814734">114</xref></sup> SCFAs,<sup><xref ref-type="bibr" rid="bibr107-2045125318814734">107</xref><xref ref-type="bibr" rid="bibr108-2045125318814734"></xref><xref ref-type="bibr" rid="bibr109-2045125318814734"></xref><xref ref-type="bibr" rid="bibr110-2045125318814734"></xref>–<xref ref-type="bibr" rid="bibr111-2045125318814734">111</xref></sup> ClpB,<sup><xref ref-type="bibr" rid="bibr121-2045125318814734">121</xref></sup> EPHX2,<sup><xref ref-type="bibr" rid="bibr104-2045125318814734">104</xref></sup> EBF1,<sup><xref ref-type="bibr" rid="bibr69-2045125318814734">69</xref>,<xref ref-type="bibr" rid="bibr70-2045125318814734">70</xref></sup> TNXB,<sup><xref ref-type="bibr" rid="bibr87-2045125318814734">87</xref>,<xref ref-type="bibr" rid="bibr88-2045125318814734">88</xref></sup> which, in addition to other MHC proteins, are pathophysiological key molecules. These molecules may offer potential as future drug targets, if inhibitors or analogues of these molecules become available.</p>
<p>Zheng and colleagues performed experiments in germ-free mice. The transplantation of microbiota from patients suffering from a depressive episode resulted in depression-like behaviours, whereas colonization with microbiota derived from healthy controls did not.<sup><xref ref-type="bibr" rid="bibr174-2045125318814734">174</xref></sup> Therefore, faecal microbiota transplant may become a future therapeutic option for patients with EDs. In a more specific approach, it has been shown that <italic>Lactobacillus rhamnosus</italic> alleviates OCD-like and anxious behaviours in animals, possibly by altering gamma-aminobutyric acid (GABA) receptors or even synthesizing and releasing GABA.<sup><xref ref-type="bibr" rid="bibr175-2045125318814734">175</xref></sup> Therefore, <italic>L. rhamnosus</italic> may have beneficial psychological effects in patients suffering from psychiatric disorders with these symptoms, including those with OCD, anxiety or AN.</p>
<p>Taken together, genetic research in EDs has changed the way we think about AN, BN and BED, as it clearly demonstrates the importance of biological factors in the pathophysiology of EDs. This knowledge will hopefully lead to novel therapeutic ideas and eventually put an end to the management of life-threatening medical complications, nutritional rehabilitation, including tube feeding and other unpleasant coercive measures, and often unsuccessful psychosocial therapy being the only treatment options for EDs like AN.</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding:</bold> This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="COI-statement">
<p><bold>Conflict of interest statement:</bold> Janet Treasure declares that she will be the Principal Investigator of a randomized controlled trial evaluating the effects of naloxone hydrochloride nasal spray on eating behaviours in bulimia nervosa sponsored by Opiant Pharmaceuticals. All other authors declare no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2045125318814734">
<label>1</label>
<mixed-citation publication-type="book">
<person-group person-group-type="editor"><name><surname>Hardacre</surname><given-names>H.</given-names></name></person-group>
<article-title>Ancestors: ancestor worship</article-title>. In: <person-group person-group-type="editor"><name><surname>Jones</surname><given-names>L</given-names></name></person-group> (ed.) <source/>Encyclopedia of religion. <edition>2nd ed.</edition>
<publisher-loc>Detroit</publisher-loc>: <publisher-name>Thomson Gale</publisher-name>, <year>2005</year>, pp. <fpage>320</fpage>–<lpage>325</lpage>.</mixed-citation>
</ref>
<ref id="bibr2-2045125318814734">
<label>2</label>
<mixed-citation publication-type="book">
<collab>Catholic Truth Society</collab>. <source/>The CTS new catholic bible. <edition>1st ed</edition>
<publisher-loc>London</publisher-loc>: <publisher-name>Catholic Truth Society</publisher-name>, <year>2007</year>, pp. <fpage>12</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="bibr3-2045125318814734">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mendel</surname><given-names>JG.</given-names></name></person-group>
<article-title>Versuche über Pflanzenhybriden</article-title>. <source/>Verh Naturforsch Ver Brünn
<year>1866</year>; <volume>4</volume>: <fpage>3</fpage>–<lpage>47</lpage>.</mixed-citation>
</ref>
<ref id="bibr4-2045125318814734">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mott</surname><given-names>FW.</given-names></name></person-group>
<article-title>The inborn factors of nervous and mental disease</article-title>. <source/>Brain
<year>1911</year>; <volume>34</volume>: <fpage>73</fpage>–<lpage>101</lpage>.</mixed-citation>
</ref>
<ref id="bibr5-2045125318814734">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schulze</surname><given-names>TG</given-names></name><name><surname>Fangerau</surname><given-names>H</given-names></name><name><surname>Propping</surname><given-names>P.</given-names></name></person-group>
<article-title>From degeneration to genetic susceptibility, from eugenics to genethics, from Bezugsziffer to LOD score: the history of psychiatric genetics</article-title>. <source/>Int Rev Psychiatry
<year>2004</year>; <volume>16</volume>: <fpage>246</fpage>–<lpage>259</lpage>.<pub-id pub-id-type="pmid">16194759</pub-id></mixed-citation>
</ref>
<ref id="bibr6-2045125318814734">
<label>6</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Schmuhl</surname><given-names>H.</given-names></name></person-group>
<source/>Rassenhygiene, Nationalsozialismus, Euthanasie: Von der Verhütung zur Vernichtung “lebensunwerten Lebens”. <edition>2nd ed.</edition>
<publisher-loc>Göttingen</publisher-loc>: <publisher-name>Vandenhoeck and Ruprecht</publisher-name>, <year>1992</year>, p. <fpage>152</fpage>.</mixed-citation>
</ref>
<ref id="bibr7-2045125318814734">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weber</surname><given-names>MM.</given-names></name></person-group>
<article-title>Ernst Rüdin, 1874–1952: a German psychiatrist and geneticist</article-title>. <source/>Am J Med Genet A
<year>1996</year>; <volume>67</volume>: <fpage>323</fpage>–<lpage>331</lpage>.</mixed-citation>
</ref>
<ref id="bibr8-2045125318814734">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schulz</surname><given-names>B.</given-names></name></person-group>
<article-title>Ernst Rüdin</article-title>. <source/>Arch Psychiatr Neurol
<year>1953</year>; <volume>190</volume>: <fpage>187</fpage>–<lpage>195</lpage>.</mixed-citation>
</ref>
<ref id="bibr9-2045125318814734">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kösters</surname><given-names>G</given-names></name><name><surname>Steinberg</surname><given-names>H</given-names></name><name><surname>Kirkby</surname><given-names>KC</given-names></name><etal>et al</etal></person-group>
<article-title>Ernst Rüdin’s unpublished 1922–1925 study ‘Inheritance of manic-depressive insanity’: genetic research findings subordinated to eugenic ideology</article-title>. <source/>PLoS Genet
<year>2015</year>; <volume>11</volume>: <fpage>e1005524</fpage>.<pub-id pub-id-type="pmid">26544949</pub-id></mixed-citation>
</ref>
<ref id="bibr10-2045125318814734">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dahm</surname><given-names>R.</given-names></name></person-group>
<article-title>Discovering DNA: Friedrich Miescher and the early years of nucleic acid research</article-title>. <source/>Hum Genet
<year>2008</year>; <volume>122</volume>: <fpage>565</fpage>–<lpage>581</lpage>.<pub-id pub-id-type="pmid">17901982</pub-id></mixed-citation>
</ref>
<ref id="bibr11-2045125318814734">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Watson</surname><given-names>JD</given-names></name><name><surname>Crick</surname><given-names>FH.</given-names></name></person-group>
<article-title>Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid</article-title>. <source/>Nature
<year>1953</year>; <volume>171</volume>: <fpage>737</fpage>–<lpage>738</lpage>.<pub-id pub-id-type="pmid">13054692</pub-id></mixed-citation>
</ref>
<ref id="bibr12-2045125318814734">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raju</surname><given-names>TN.</given-names></name></person-group>
<article-title>The Nobel Chronicles. 1968: Har Khorana (b 1922); Robert Holley (1922-93); Marshall Nirenberg (b 1927)</article-title>. <source/>Lancet
<year>1999</year>; <volume>354</volume>: <fpage>690</fpage>.<pub-id pub-id-type="pmid">10466708</pub-id></mixed-citation>
</ref>
<ref id="bibr13-2045125318814734">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>CM</given-names></name><name><surname>Knight</surname><given-names>J.</given-names></name></person-group>
<article-title>Introduction to genetic association studies</article-title>. <source/>Cold Spring Harb Protoc
<year>2012</year>; <volume>2012</volume>: <fpage>297</fpage>–<lpage>306</lpage>.<pub-id pub-id-type="pmid">22383645</pub-id></mixed-citation>
</ref>
<ref id="bibr14-2045125318814734">
<label>14</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gurling</surname><given-names>H.</given-names></name></person-group>
<article-title>Candidate genes and favoured loci: strategies for molecular genetic research into schizophrenia, manic depression, autism, alcoholism and Alzheimer’s disease</article-title>. <source/>Psychiatr Dev
<year>1986</year>; <volume>4</volume>: <fpage>289</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">3554229</pub-id></mixed-citation>
</ref>
<ref id="bibr15-2045125318814734">
<label>15</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klein</surname><given-names>RJ</given-names></name><name><surname>Zeiss</surname><given-names>C</given-names></name><name><surname>Chew</surname><given-names>EY</given-names></name><etal>et al</etal></person-group>
<article-title>Complement factor H polymorphism in age-related macular degeneration</article-title>. <source/>Science
<year>2005</year>; <volume>308</volume>: <fpage>385</fpage>–<lpage>389</lpage>.<pub-id pub-id-type="pmid">15761122</pub-id></mixed-citation>
</ref>
<ref id="bibr16-2045125318814734">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Agrawal</surname><given-names>A</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name><etal>et al</etal></person-group>
<article-title>Psychiatric genomics: an update and an agenda</article-title>. <source/>Am J Psychiatry
<year>2018</year>; <volume>175</volume>: <fpage>15</fpage>–<lpage>27</lpage>.<pub-id pub-id-type="pmid">28969442</pub-id></mixed-citation>
</ref>
<ref id="bibr17-2045125318814734">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hegstrand</surname><given-names>LR</given-names></name><name><surname>Hine</surname><given-names>RJ.</given-names></name></person-group>
<article-title>Variations of brain histamine levels in germ-free and nephrectomized rats</article-title>. <source/>Neurochem Res
<year>1986</year>; <volume>11</volume>:<fpage>185</fpage>–<lpage>191</lpage>.<pub-id pub-id-type="pmid">2422565</pub-id></mixed-citation>
</ref>
<ref id="bibr18-2045125318814734">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prescott</surname><given-names>SL.</given-names></name></person-group>
<article-title>History of medicine: origin of the term microbiome and why it matters</article-title>. <source/>Hum Microbiome J
<year>2017</year>; <volume>4</volume>: <fpage>24</fpage>–<lpage>25</lpage>.</mixed-citation>
</ref>
<ref id="bibr19-2045125318814734">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Himmerich</surname><given-names>H</given-names></name><name><surname>Minkwitz</surname><given-names>J</given-names></name><name><surname>Kirkby</surname><given-names>KC.</given-names></name></person-group>
<article-title>Weight gain and metabolic changes during treatment with antipsychotics and antidepressants</article-title>. <source/>Endocr Metab Immune Disord Drug Targets
<year>2015</year>; <volume>15</volume>: <fpage>252</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">26100432</pub-id></mixed-citation>
</ref>
<ref id="bibr20-2045125318814734">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Savage</surname><given-names>DC.</given-names></name></person-group>
<article-title>Microbial ecology of the gastrointestinal tract</article-title>. <source/>Annu Rev Microbiol
<year>1977</year>; <volume>31</volume>: <fpage>107</fpage>–<lpage>133</lpage>.<pub-id pub-id-type="pmid">334036</pub-id></mixed-citation>
</ref>
<ref id="bibr21-2045125318814734">
<label>21</label>
<mixed-citation publication-type="journal">
<collab>NIH HMP Working Group</collab>, <person-group person-group-type="author"><name><surname>Peterson</surname><given-names>J</given-names></name><name><surname>Garges</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>The NIH human microbiome project</article-title>. <source/>Genome Res
<year>2009</year>; <volume>19</volume>: <fpage>2317</fpage>–<lpage>2323</lpage>.<pub-id pub-id-type="pmid">19819907</pub-id></mixed-citation>
</ref>
<ref id="bibr22-2045125318814734">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>TSB</given-names></name><name><surname>Raes</surname><given-names>J</given-names></name><name><surname>Bork</surname><given-names>P.</given-names></name></person-group>
<article-title>The human gut microbiome: from association to modulation</article-title>. <source/>Cell
<year>2018</year>; <volume>172</volume>: <fpage>1198</fpage>–<lpage>1215</lpage>.<pub-id pub-id-type="pmid">29522742</pub-id></mixed-citation>
</ref>
<ref id="bibr23-2045125318814734">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Relman</surname><given-names>DA</given-names></name><name><surname>Falkow</surname><given-names>S.</given-names></name></person-group>
<article-title>The meaning and impact of the human genome sequence for microbiology</article-title>. <source/>Trends Microbiol
<year>2001</year>; <volume>9</volume>: <fpage>206</fpage>–<lpage>208</lpage>.<pub-id pub-id-type="pmid">11336835</pub-id></mixed-citation>
</ref>
<ref id="bibr24-2045125318814734">
<label>24</label>
<mixed-citation publication-type="book">
<collab>American Psychiatric Association</collab>. <source/>Diagnostic and statistical manual of mental disorders. <edition>5th ed</edition>
<publisher-loc>Arlington</publisher-loc>: <publisher-name>APA Publishing</publisher-name>, <year>2013</year>.</mixed-citation>
</ref>
<ref id="bibr25-2045125318814734">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Himmerich</surname><given-names>H</given-names></name><name><surname>Treasure</surname><given-names>J.</given-names></name></person-group>
<article-title>Psychopharmacological advances in eating disorders</article-title>. <source/>Expert Rev Clin Pharmacol
<year>2018</year>; <volume>11</volume>: <fpage>95</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="pmid">28933969</pub-id></mixed-citation>
</ref>
<ref id="bibr26-2045125318814734">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Himmerich</surname><given-names>H</given-names></name><name><surname>Schönknecht</surname><given-names>P</given-names></name><name><surname>Heitmann</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Laboratory parameters and appetite regulators in patients with anorexia nervosa</article-title>. <source/>J Psychiatr Pract
<year>2010</year>; <volume>16</volume>: <fpage>82</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="pmid">20511732</pub-id></mixed-citation>
</ref>
<ref id="bibr27-2045125318814734">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tozzi</surname><given-names>F</given-names></name><name><surname>Thornton</surname><given-names>L</given-names></name><name><surname>Klump</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Symptom fluctuation in eating disorders: correlates of diagnostic crossover</article-title>. <source/>Am J Psychiatry
<year>2005</year>; <volume>162</volume>: <fpage>732</fpage>–<lpage>740</lpage>.<pub-id pub-id-type="pmid">15800146</pub-id></mixed-citation>
</ref>
<ref id="bibr28-2045125318814734">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hay</surname><given-names>P</given-names></name><name><surname>Fairburn</surname><given-names>C.</given-names></name></person-group>
<article-title>The validity of the DSM-IV scheme for classifying bulimic eating disorders</article-title>. <source/>Int J Eat Disord
<year>1998</year>; <volume>23</volume>: <fpage>7</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">9429914</pub-id></mixed-citation>
</ref>
<ref id="bibr29-2045125318814734">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Thornton</surname><given-names>LM</given-names></name><name><surname>Root</surname><given-names>TL</given-names></name><etal>et al</etal></person-group>
<article-title>Understanding the relation between anorexia nervosa and bulimia nervosa in a Swedish national twin sample</article-title>. <source/>Biol Psychiatry
<year>2010</year>; <volume>67</volume>: <fpage>71</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="pmid">19828139</pub-id></mixed-citation>
</ref>
<ref id="bibr30-2045125318814734">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glenny</surname><given-names>EM</given-names></name><name><surname>Bulik-Sullivan</surname><given-names>EC</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><etal>et al</etal></person-group>
<article-title>Eating disorders and the intestinal microbiota: mechanisms of energy homeostasis and behavioral influence</article-title>. <source/>Curr Psychiatry Rep
<year>2017</year>; <volume>19</volume>: <fpage>51</fpage>.<pub-id pub-id-type="pmid">28676966</pub-id></mixed-citation>
</ref>
<ref id="bibr31-2045125318814734">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borgo</surname><given-names>F</given-names></name><name><surname>Riva</surname><given-names>A</given-names></name><name><surname>Benetti</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Microbiota in anorexia nervosa: the triangle between bacterial species, metabolites and psychological tests</article-title>. <source/>PLoS One
<year>2017</year>; <volume>12</volume>: <fpage>e0179739</fpage>.<pub-id pub-id-type="pmid">28636668</pub-id></mixed-citation>
</ref>
<ref id="bibr32-2045125318814734">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kleiman</surname><given-names>SC</given-names></name><name><surname>Glenny</surname><given-names>EM</given-names></name><name><surname>Bulik-Sullivan</surname><given-names>EC</given-names></name><etal>et al</etal></person-group>
<article-title>Daily changes in composition and diversity of the intestinal microbiota in patients with anorexia nervosa: a series of three cases</article-title>. <source/>Eur Eat Disord Rev
<year>2017</year>; <volume>25</volume>: <fpage>423</fpage>–<lpage>427</lpage>.<pub-id pub-id-type="pmid">28586130</pub-id></mixed-citation>
</ref>
<ref id="bibr33-2045125318814734">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tremaroli</surname><given-names>V</given-names></name><name><surname>Bäckhed</surname><given-names>F.</given-names></name></person-group>
<article-title>Functional interactions between the gut microbiota and host metabolism</article-title>. <source/>Nature
<year>2012</year>; <volume>489</volume>: <fpage>242</fpage>–<lpage>249</lpage>.<pub-id pub-id-type="pmid">22972297</pub-id></mixed-citation>
</ref>
<ref id="bibr34-2045125318814734">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lam</surname><given-names>YY</given-names></name><name><surname>Maguire</surname><given-names>S</given-names></name><name><surname>Palacios</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Are the gut bacteria telling us to eat or not to eat? Reviewing the role of gut microbiota in the etiology, disease progression and treatment of eating disorders</article-title>. <source/>Nutrients
<year>2017</year>; <volume>14</volume>; <volume>9</volume>: <fpage>6</fpage>.</mixed-citation>
</ref>
<ref id="bibr35-2045125318814734">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trace</surname><given-names>SE</given-names></name><name><surname>Baker</surname><given-names>JH</given-names></name><name><surname>Peñas-Lledó</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>The genetics of eating disorders</article-title>. <source/>Annu Rev Clin Psychol
<year>2013</year>; <volume>9</volume>: <fpage>589</fpage>–<lpage>620</lpage>.<pub-id pub-id-type="pmid">23537489</pub-id></mixed-citation>
</ref>
<ref id="bibr36-2045125318814734">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Wade</surname><given-names>TD</given-names></name><etal>et al</etal></person-group>
<article-title>Twin studies of eating disorders: a review</article-title>. <source/>Int J Eat Disord
<year>2000</year>; <volume>27</volume>: <fpage>1</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">10590444</pub-id></mixed-citation>
</ref>
<ref id="bibr37-2045125318814734">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Kleiman</surname><given-names>SC</given-names></name><name><surname>Yilmaz</surname><given-names>Z.</given-names></name></person-group>
<article-title>Genetic epidemiology of eating disorders</article-title>. <source/>Curr Opin Psychiatry
<year>2016</year>; <volume>29</volume>: <fpage>383</fpage>–<lpage>388</lpage>.<pub-id pub-id-type="pmid">27532941</pub-id></mixed-citation>
</ref>
<ref id="bibr38-2045125318814734">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shih</surname><given-names>PA</given-names></name><name><surname>Woodside</surname><given-names>DB.</given-names></name></person-group>
<article-title>Contemporary views on the genetics of anorexia nervosa</article-title>. <source/>Eur Neuropsychopharmacol
<year>2016</year>; <volume>26</volume>: <fpage>663</fpage>–<lpage>673</lpage>.<pub-id pub-id-type="pmid">26944296</pub-id></mixed-citation>
</ref>
<ref id="bibr39-2045125318814734">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hinney</surname><given-names>A</given-names></name><name><surname>Friedel</surname><given-names>S</given-names></name><name><surname>Remschmidt</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Genetic risk factors in eating disorders</article-title>. <source/>Am J Pharmacogenomics
<year>2004</year>; <volume>4</volume>: <fpage>209</fpage>–<lpage>223</lpage>.<pub-id pub-id-type="pmid">15287815</pub-id></mixed-citation>
</ref>
<ref id="bibr40-2045125318814734">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>Z</given-names></name><name><surname>Hardaway</surname><given-names>JA</given-names></name><name><surname>Bulik</surname><given-names>CM.</given-names></name></person-group>
<article-title>Genetics and epigenetics of eating disorders</article-title>. <source/>Adv Genomics Genet
<year>2015</year>; <volume>5</volume>: <fpage>131</fpage>–<lpage>150</lpage>.<pub-id pub-id-type="pmid">27013903</pub-id></mixed-citation>
</ref>
<ref id="bibr41-2045125318814734">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lilenfeld</surname><given-names>L</given-names></name><name><surname>Kaye</surname><given-names>W</given-names></name><name><surname>Greeno</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>A controlled family study of restricting anorexia and bulimia nervosa: comorbidity in probands and disorders in first-degree relatives</article-title>. <source/>Arch Gen Psychiatry
<year>1998</year>; <volume>55</volume>: <fpage>603</fpage>–<lpage>610</lpage>.<pub-id pub-id-type="pmid">9672050</pub-id></mixed-citation>
</ref>
<ref id="bibr42-2045125318814734">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strober</surname><given-names>M</given-names></name><name><surname>Freeman</surname><given-names>R</given-names></name><name><surname>Lampert</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes</article-title>. <source/>Am J Psychiatry
<year>2000</year>; <volume>157</volume>: <fpage>393</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="pmid">10698815</pub-id></mixed-citation>
</ref>
<ref id="bibr43-2045125318814734">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Strober</surname><given-names>M</given-names></name><name><surname>Freeman</surname><given-names>R</given-names></name><name><surname>Lampert</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Males with anorexia nervosa: a controlled study of eating disorders in first-degree relatives</article-title>. <source/>Int J Eat Disord
<year>2001</year>; <volume>29</volume>: <fpage>263</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">11262504</pub-id></mixed-citation>
</ref>
<ref id="bibr44-2045125318814734">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Tozzi</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Prevalence, heritability, and prospective risk factors for anorexia nervosa</article-title>. <source/>Arch Gen Psychiatry
<year>2006</year>; <volume>63</volume>: <fpage>305</fpage>–<lpage>312</lpage>.<pub-id pub-id-type="pmid">16520436</pub-id></mixed-citation>
</ref>
<ref id="bibr45-2045125318814734">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holland</surname><given-names>AJ</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name><name><surname>Murray</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Crisp Anorexia nervosa: a study of 34 twin pairs and one set of triplets</article-title>. <source/>Br J Psychiatry
<year>1984</year>; <volume>145</volume>: <fpage>414</fpage>–<lpage>419</lpage>.<pub-id pub-id-type="pmid">6593110</pub-id></mixed-citation>
</ref>
<ref id="bibr46-2045125318814734">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Javaras</surname><given-names>KN</given-names></name><name><surname>Laird</surname><given-names>NM</given-names></name><name><surname>Reichborn-Kjennerud</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Familiality and heritability of binge eating disorder: results of a case-control family study and a twin study</article-title>. <source/>Int J Eat Disord
<year>2008</year>; <volume>41</volume>: <fpage>174</fpage>–<lpage>179</lpage>.<pub-id pub-id-type="pmid">18095307</pub-id></mixed-citation>
</ref>
<ref id="bibr47-2045125318814734">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reichborn-Kjennerud</surname><given-names>T</given-names></name><name><surname>Bulik</surname><given-names>C</given-names></name><name><surname>Tambs</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Genetic and environmental influences on binge eating in the absence of compensatory behaviours: a population-based twin study</article-title>. <source/>Int J Eat Disord
<year>2004</year>; <volume>36</volume>: <fpage>307</fpage>–<lpage>314</lpage>.<pub-id pub-id-type="pmid">15478129</pub-id></mixed-citation>
</ref>
<ref id="bibr48-2045125318814734">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thornton</surname><given-names>LM</given-names></name><name><surname>Mazzeo</surname><given-names>SE</given-names></name><name><surname>Bulik</surname><given-names>CM.</given-names></name></person-group>
<article-title>The heritability of eating disorders: methods and current findings</article-title>. <source/>Curr Top Behav Neurosci
<year>2011</year>; <volume>6</volume>: <fpage>141</fpage>–<lpage>156</lpage>.<pub-id pub-id-type="pmid">21243474</pub-id></mixed-citation>
</ref>
<ref id="bibr49-2045125318814734">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klump</surname><given-names>KL</given-names></name><name><surname>Suisman</surname><given-names>JL</given-names></name><name><surname>Burt</surname><given-names>SA.</given-names></name></person-group>
<article-title>Genetic and environmental influences on disordered eating: an adoption study</article-title>. <source/>J Abnorm Psychol
<year>2009</year>; <volume>118</volume>: <fpage>797</fpage>–<lpage>805</lpage>.<pub-id pub-id-type="pmid">19899849</pub-id></mixed-citation>
</ref>
<ref id="bibr50-2045125318814734">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Von Ranson</surname><given-names>KM</given-names></name><name><surname>Klump</surname><given-names>KL</given-names></name><name><surname>Iacono</surname><given-names>WG</given-names></name><etal>et al</etal></person-group>
<article-title>The Minnesota eating behavior survey: a brief measure of disordered eating attitudes and behaviors</article-title>. <source/>Eat Behav
<year>2005</year>; <volume>6</volume>: <fpage>373</fpage>–<lpage>392</lpage>.<pub-id pub-id-type="pmid">16257811</pub-id></mixed-citation>
</ref>
<ref id="bibr51-2045125318814734">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grice</surname><given-names>DE</given-names></name><name><surname>Halmi</surname><given-names>KA</given-names></name><name><surname>Fichter</surname><given-names>MM</given-names></name><etal>et al</etal></person-group>
<article-title>Evidence for a susceptibility gene for anorexia nervosa on chromosome 1</article-title>. <source/>Am J Hum Genet
<year>2002</year>; <volume>70</volume>: <fpage>787</fpage>–<lpage>792</lpage>.<pub-id pub-id-type="pmid">11799475</pub-id></mixed-citation>
</ref>
<ref id="bibr52-2045125318814734">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bergen</surname><given-names>AW</given-names></name><name><surname>Van den Bree</surname><given-names>MB</given-names></name><name><surname>Yeager</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Candidate genes for anorexia nervosa in the 1p33–36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa</article-title>. <source/>Mol Psychiatry
<year>2003</year>; <volume>8</volume>: <fpage>397</fpage>–<lpage>406</lpage>.<pub-id pub-id-type="pmid">12740597</pub-id></mixed-citation>
</ref>
<ref id="bibr53-2045125318814734">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Bacanu</surname><given-names>SA</given-names></name><name><surname>Klump</surname><given-names>KL</given-names></name><etal>et al</etal></person-group>
<article-title>Linkage analysis of anorexia nervosa incorporating behavioral covariates</article-title>. <source/>Hum Mol Genet
<year>2002</year>; <volume>11</volume>: <fpage>689</fpage>–<lpage>696</lpage>.<pub-id pub-id-type="pmid">11912184</pub-id></mixed-citation>
</ref>
<ref id="bibr54-2045125318814734">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Bacanu</surname><given-names>SA</given-names></name><etal>et al</etal></person-group>
<article-title>Significant linkage on chromosome 10p in families with bulimia nervosa</article-title>. <source/>Am J Hum Genet
<year>2003</year>; <volume>72</volume>: <fpage>200</fpage>–<lpage>207</lpage>.<pub-id pub-id-type="pmid">12476400</pub-id></mixed-citation>
</ref>
<ref id="bibr55-2045125318814734">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCarroll</surname><given-names>SA</given-names></name><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Hyman</surname><given-names>SE.</given-names></name></person-group>
<article-title>Genome-scale neurogenetics: methodology and meaning</article-title>. <source/>Nat Neurosci
<year>2014</year>; <volume>17</volume>: <fpage>756</fpage>–<lpage>763</lpage>.<pub-id pub-id-type="pmid">24866041</pub-id></mixed-citation>
</ref>
<ref id="bibr56-2045125318814734">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Pertsemlidis</surname><given-names>A</given-names></name><name><surname>Kotowski</surname><given-names>IK</given-names></name><etal>et al</etal></person-group>
<article-title>Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9</article-title>. <source/>Nat Genet
<year>2005</year>; <volume>37</volume>: <fpage>161</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">15654334</pub-id></mixed-citation>
</ref>
<ref id="bibr57-2045125318814734">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rask-Andersen</surname><given-names>M</given-names></name><name><surname>Olszewski</surname><given-names>PK</given-names></name><name><surname>Levine</surname><given-names>AS</given-names></name><etal>et al</etal></person-group>
<article-title>Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake</article-title>. <source/>Brain Res Rev
<year>2010</year>; <volume>62</volume>: <fpage>147</fpage>–<lpage>164</lpage>.<pub-id pub-id-type="pmid">19931559</pub-id></mixed-citation>
</ref>
<ref id="bibr58-2045125318814734">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ando</surname><given-names>T</given-names></name><name><surname>Komaki</surname><given-names>G</given-names></name><name><surname>Naruo</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa</article-title>. <source/>Am J Med Genet B Neuropsychiatr Genet
<year>2006</year>; <volume>141B</volume>: <fpage>929</fpage>–<lpage>934</lpage>.<pub-id pub-id-type="pmid">16921495</pub-id></mixed-citation>
</ref>
<ref id="bibr59-2045125318814734">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>M</given-names></name><name><surname>Naessen</surname><given-names>S</given-names></name><name><surname>Dahlman</surname><given-names>I</given-names></name><etal>et al</etal></person-group>
<article-title>Association of estrogen receptor beta gene polymorphisms with bulimic disease in women</article-title>. <source/>Mol Psychiatry
<year>2004</year>; <volume>9</volume>: <fpage>28</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">14699439</pub-id></mixed-citation>
</ref>
<ref id="bibr60-2045125318814734">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monteleone</surname><given-names>P</given-names></name><name><surname>Tortorella</surname><given-names>A</given-names></name><name><surname>Castaldo</surname><given-names>E</given-names></name><etal>et al</etal></person-group>
<article-title>Association of a functional serotonin transporter gene polymorphism with binge eating disorder</article-title>. <source/>Am J Med Genet B Neuropsychiatr Genet
<year>2006</year>; <volume>141B</volume>: <fpage>7</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">16249995</pub-id></mixed-citation>
</ref>
<ref id="bibr61-2045125318814734">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muller</surname><given-names>TD</given-names></name><name><surname>Greene</surname><given-names>BH</given-names></name><name><surname>Bellodi</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa</article-title>. <source/>Obes Facts
<year>2012</year>; <volume>5</volume>: <fpage>408</fpage>–<lpage>419</lpage>.<pub-id pub-id-type="pmid">22797368</pub-id></mixed-citation>
</ref>
<ref id="bibr62-2045125318814734">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jonassaint</surname><given-names>CR</given-names></name><name><surname>Szatkiewicz</surname><given-names>JP</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name><etal>et al</etal></person-group>
<article-title>Absence of association between specific common variants of the obesity-related FTO gene and psychological and behavioral eating disorder phenotypes</article-title>. <source/>Am J Med Genet B Neuropsychiatr Genet
<year>2011</year>; <volume>156B</volume>: <fpage>454</fpage>–<lpage>461</lpage>.<pub-id pub-id-type="pmid">21438147</pub-id></mixed-citation>
</ref>
<ref id="bibr63-2045125318814734">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>C</given-names></name><name><surname>Levitan</surname><given-names>RD</given-names></name><name><surname>Yilmaz</surname><given-names>Z</given-names></name><etal>et al</etal></person-group>
<article-title>Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry
<year>2012</year>; <volume>38</volume>: <fpage>328</fpage>–<lpage>335</lpage>.<pub-id pub-id-type="pmid">22579533</pub-id></mixed-citation>
</ref>
<ref id="bibr64-2045125318814734">
<label>64</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Levitan</surname><given-names>RD</given-names></name><name><surname>Reid</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Dopamine for ‘wanting’ and opioids for ‘liking’: a comparison of obese adults with and without binge eating</article-title>. <source/>Obesity
<year>2009</year>; <volume>17</volume>: <fpage>1220</fpage>–<lpage>1225</lpage>.<pub-id pub-id-type="pmid">19282821</pub-id></mixed-citation>
</ref>
<ref id="bibr65-2045125318814734">
<label>65</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bush</surname><given-names>WS</given-names></name><name><surname>Moore</surname><given-names>JH.</given-names></name></person-group>
<article-title>Chapter 11: Genome-wide association studies</article-title>. <source/>PLoS Comput Biol
<year>2012</year>; <volume>8</volume>: <fpage>e1002822</fpage>.<pub-id pub-id-type="pmid">23300413</pub-id></mixed-citation>
</ref>
<ref id="bibr66-2045125318814734">
<label>66</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Bloss</surname><given-names>CS</given-names></name><etal>et al</etal></person-group>
<article-title>A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa</article-title>. <source/>Mol Psychiatry
<year>2011</year>; <volume>16</volume>: <fpage>949</fpage>–<lpage>959</lpage>.<pub-id pub-id-type="pmid">21079607</pub-id></mixed-citation>
</ref>
<ref id="bibr67-2045125318814734">
<label>67</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boraska</surname><given-names>V</given-names></name><name><surname>Franklin</surname><given-names>CS</given-names></name><name><surname>Floyd</surname><given-names>JA</given-names></name><etal>et al</etal></person-group>
<article-title>A genome-wide association study of anorexia nervosa</article-title>. <source/>Mol Psychiatry
<year>2014</year>; <volume>19</volume>: <fpage>1085</fpage>–<lpage>1094</lpage>.<pub-id pub-id-type="pmid">24514567</pub-id></mixed-citation>
</ref>
<ref id="bibr68-2045125318814734">
<label>68</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duncan</surname><given-names>L</given-names></name><name><surname>Yilmaz</surname><given-names>Z</given-names></name><name><surname>Gaspar</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Significant locus and metabolic genetic correlations revealed in genome-wide association study of anorexia nervosa</article-title>. <source/>Am J Psychiatry
<year>2017</year>; <volume>174</volume>: <fpage>850</fpage>–<lpage>858</lpage>.<pub-id pub-id-type="pmid">28494655</pub-id></mixed-citation>
</ref>
<ref id="bibr69-2045125318814734">
<label>69</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Chang</surname><given-names>X</given-names></name><name><surname>Connolly</surname><given-names>JJ</given-names></name><etal>et al</etal></person-group>
<article-title>A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling</article-title>. <source/>Sci Rep
<year>2017</year>; <volume>7</volume>: <fpage>3847</fpage>.<pub-id pub-id-type="pmid">28630421</pub-id></mixed-citation>
</ref>
<ref id="bibr70-2045125318814734">
<label>70</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hagman</surname><given-names>J</given-names></name><name><surname>Belanger</surname><given-names>C</given-names></name><name><surname>Travis</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression</article-title>. <source/>Genes Dev
<year>1993</year>; <volume>7</volume>: <fpage>760</fpage>–<lpage>773</lpage>.<pub-id pub-id-type="pmid">8491377</pub-id></mixed-citation>
</ref>
<ref id="bibr71-2045125318814734">
<label>71</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>H</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Takami</surname><given-names>Y</given-names></name><etal>et al</etal></person-group>
<article-title>EBF1 acts as a powerful repressor of Blimp-1 gene expression in immature B cells</article-title>. <source/>Biochem Biophys Res Commun
<year>2012</year>; <volume>422</volume>: <fpage>780</fpage>–<lpage>785</lpage>.<pub-id pub-id-type="pmid">22634309</pub-id></mixed-citation>
</ref>
<ref id="bibr72-2045125318814734">
<label>72</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huckins</surname><given-names>LM</given-names></name><name><surname>Hatzikotoulas</surname><given-names>K</given-names></name><name><surname>Southam</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa</article-title>. <source/>Mol Psychiatry
<year>2018</year>; <volume>23</volume>: <fpage>1169</fpage>–<lpage>1180</lpage>.<pub-id pub-id-type="pmid">29155802</pub-id></mixed-citation>
</ref>
<ref id="bibr73-2045125318814734">
<label>73</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McGough</surname><given-names>IJ</given-names></name><name><surname>Steinberg</surname><given-names>F</given-names></name><name><surname>Gallon</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Identification of molecular heterogeneity in SNX27-retromer-mediated endosome-to-plasma-membrane recycling</article-title>. <source/>J Cell Sci
<year>2014</year>; <volume>127</volume>: <fpage>4940</fpage>–<lpage>4953</lpage>.<pub-id pub-id-type="pmid">25278552</pub-id></mixed-citation>
</ref>
<ref id="bibr74-2045125318814734">
<label>74</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name><etal>et al</etal></person-group>
<article-title>An atlas of genetic correlations across human diseases and traits</article-title>. <source/>Nat Genet
<year>2015</year>; <volume>47</volume>: <fpage>1236</fpage>–<lpage>1241</lpage>.<pub-id pub-id-type="pmid">26414676</pub-id></mixed-citation>
</ref>
<ref id="bibr75-2045125318814734">
<label>75</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nordsletten</surname><given-names>AE</given-names></name><name><surname>Larsson</surname><given-names>H</given-names></name><name><surname>Crowley</surname><given-names>JJ</given-names></name><etal>et al</etal></person-group>
<article-title>Patterns of nonrandom mating within and across 11 major psychiatric disorders</article-title>. <source/>JAMA Psychiatry
<year>2016</year>; <volume>73</volume>: <fpage>354</fpage>–<lpage>361</lpage>.<pub-id pub-id-type="pmid">26913486</pub-id></mixed-citation>
</ref>
<ref id="bibr76-2045125318814734">
<label>76</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wade</surname><given-names>TD</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Medland</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Genetic variants associated with disordered eating</article-title>. <source/>Int J Eat Disord
<year>2013</year>; <volume>46</volume>: <fpage>594</fpage>–<lpage>608</lpage>.<pub-id pub-id-type="pmid">23568457</pub-id></mixed-citation>
</ref>
<ref id="bibr77-2045125318814734">
<label>77</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kao</surname><given-names>PY</given-names></name><name><surname>Leung</surname><given-names>KH</given-names></name><name><surname>Chan</surname><given-names>LW</given-names></name><etal>et al</etal></person-group>
<article-title>Pathway analysis of complex diseases for GWAS, extending to consider rare variants, multi-omics and interactions</article-title>. <source/>Biochim Biophys Acta
<year>2017</year>; <volume>1861</volume>: <fpage>335</fpage>–<lpage>353</lpage>.</mixed-citation>
</ref>
<ref id="bibr78-2045125318814734">
<label>78</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manolio</surname><given-names>TA</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Cox</surname><given-names>NJ</given-names></name><etal>et al</etal></person-group>
<article-title>Finding the missing heritability of complex diseases</article-title>. <source/>Nature
<year>2009</year>; <volume>461</volume>: <fpage>747</fpage>–<lpage>753</lpage>.<pub-id pub-id-type="pmid">19812666</pub-id></mixed-citation>
</ref>
<ref id="bibr79-2045125318814734">
<label>79</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Qian</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Statistical analysis for genome-wide association study</article-title>. <source/>J Biomed Res
<year>2015</year>; <volume>29</volume>: <fpage>2285</fpage>–<lpage>2297</lpage>.</mixed-citation>
</ref>
<ref id="bibr80-2045125318814734">
<label>80</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Hakonarson</surname><given-names>H.</given-names></name></person-group>
<article-title>Analysing biological pathways in genome-wide association studies</article-title>. <source/>Nat Rev Genet
<year>2010</year>; <volume>11</volume>: <fpage>843</fpage>–<lpage>854</lpage>.<pub-id pub-id-type="pmid">21085203</pub-id></mixed-citation>
</ref>
<ref id="bibr81-2045125318814734">
<label>81</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>AP</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Thornton</surname><given-names>LM</given-names></name><etal>et al</etal></person-group>
<article-title>Association study of 182 candidate genes in anorexia nervosa</article-title>. <source/>Am J Med Genet B Neuropsychiatr Genet
<year>2010</year>; <volume>153</volume>: <fpage>1070</fpage>–<lpage>1080</lpage>.</mixed-citation>
</ref>
<ref id="bibr82-2045125318814734">
<label>82</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dupont</surname><given-names>C</given-names></name><name><surname>Armant</surname><given-names>DR</given-names></name><name><surname>Brenner</surname><given-names>CA.</given-names></name></person-group>
<article-title>Epigenetics: definition, mechanisms and clinical perspective</article-title>. <source/>Semin Reprod Med
<year>2009</year>; <volume>27</volume>: <fpage>351</fpage>–<lpage>357</lpage>.<pub-id pub-id-type="pmid">19711245</pub-id></mixed-citation>
</ref>
<ref id="bibr83-2045125318814734">
<label>83</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gomes</surname><given-names>AQ</given-names></name><name><surname>Nolasco</surname><given-names>S</given-names></name><name><surname>Soares</surname><given-names>H.</given-names></name></person-group>
<article-title>Non-coding RNAs: multi-tasking molecules in the cell</article-title>. <source/>Int J Mol Sci
<year>2013</year>; <volume>14</volume>: <fpage>16010</fpage>–<lpage>16039</lpage>.<pub-id pub-id-type="pmid">23912238</pub-id></mixed-citation>
</ref>
<ref id="bibr84-2045125318814734">
<label>84</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frieling</surname><given-names>H</given-names></name><name><surname>Gozner</surname><given-names>A</given-names></name><name><surname>Römer</surname><given-names>KD</given-names></name><etal>et al</etal></person-group>
<article-title>Global DNA hypomethylation and DNA hypermethylation of the alpha synuclein promoter in females with anorexia nervosa</article-title>. <source/>Mol Psychiatry
<year>2007</year>; <volume>12</volume>: <fpage>229</fpage>–<lpage>230</lpage>.<pub-id pub-id-type="pmid">17325715</pub-id></mixed-citation>
</ref>
<ref id="bibr85-2045125318814734">
<label>85</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tremolizzo</surname><given-names>L</given-names></name><name><surname>Conti</surname><given-names>E</given-names></name><name><surname>Bomba</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents</article-title>. <source/>World J Biol Psychiatry
<year>2014</year>; <volume>15</volume>: <fpage>327</fpage>–<lpage>333</lpage>.<pub-id pub-id-type="pmid">24286295</pub-id></mixed-citation>
</ref>
<ref id="bibr86-2045125318814734">
<label>86</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saffrey</surname><given-names>R</given-names></name><name><surname>Novakovic</surname><given-names>B</given-names></name><name><surname>Wade</surname><given-names>TD.</given-names></name></person-group>
<article-title>Assessing global and gene specific DNA methylation in anorexia nervosa: a pilot study</article-title>. <source/>Int J Eat Disord
<year>2014</year>; <volume>47</volume>: <fpage>206</fpage>–<lpage>210</lpage>.<pub-id pub-id-type="pmid">24115305</pub-id></mixed-citation>
</ref>
<ref id="bibr87-2045125318814734">
<label>87</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Booij</surname><given-names>L</given-names></name><name><surname>Casey</surname><given-names>KF</given-names></name><name><surname>Antunes</surname><given-names>JM</given-names></name><etal>et al</etal></person-group>
<article-title>DNA methylation in individuals with anorexia nervosa and in matched normal-eater controls: a genome-wide study</article-title>. <source/>Int J Eat Disord
<year>2015</year>; <volume>48</volume>: <fpage>874</fpage>–<lpage>882</lpage>.<pub-id pub-id-type="pmid">25808061</pub-id></mixed-citation>
</ref>
<ref id="bibr88-2045125318814734">
<label>88</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kesselmeier</surname><given-names>M</given-names></name><name><surname>Pütter</surname><given-names>C</given-names></name><name><surname>Volckmar</surname><given-names>AL</given-names></name><etal>et al</etal></person-group>
<article-title>High-throughput DNA methylation analysis in anorexia nervosa confirms TNXB hypermethylation</article-title>. <source/>World J Biol Psychiatry
<year>2018</year>; <volume>19</volume>: <fpage>187</fpage>–<lpage>199</lpage>.<pub-id pub-id-type="pmid">27367046</pub-id></mixed-citation>
</ref>
<ref id="bibr89-2045125318814734">
<label>89</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bristow</surname><given-names>J</given-names></name><name><surname>Tee</surname><given-names>MK</given-names></name><name><surname>Gitelman</surname><given-names>SE</given-names></name><etal>et al</etal></person-group>
<article-title>Tenascin-X - a novel extracellular-matrix protein encoded by the human Xb gene overlapping P450c21b</article-title>. <source/>J Cell Biol
<year>1993</year>; <volume>122</volume>: <fpage>265</fpage>–<lpage>278</lpage>.<pub-id pub-id-type="pmid">7686164</pub-id></mixed-citation>
</ref>
<ref id="bibr90-2045125318814734">
<label>90</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>WY</given-names></name><name><surname>Kim</surname><given-names>MS</given-names></name><name><surname>Shanbhag</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects</article-title>. <source/>Am J Med Genet A
<year>2009</year>; <volume>149</volume>: <fpage>2803</fpage>–<lpage>2808</lpage>.</mixed-citation>
</ref>
<ref id="bibr91-2045125318814734">
<label>91</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weissensteiner</surname><given-names>T</given-names></name><name><surname>Lanchbury</surname><given-names>JS.</given-names></name></person-group>
<article-title>Allelic polymorphism of two multifunctional regions in the central human MHC: tenascin X, XB-S and YB, and their duplicated fragments XA and YA</article-title>. <source/>Eur J Immunogenet
<year>1997</year>; <volume>24</volume>: <fpage>201</fpage>–<lpage>209</lpage>.<pub-id pub-id-type="pmid">9226126</pub-id></mixed-citation>
</ref>
<ref id="bibr92-2045125318814734">
<label>92</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quach</surname><given-names>A</given-names></name><name><surname>Levine</surname><given-names>ME</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Epigenetic clock analysis of diet, exercise, education, and lifestyle factors</article-title>. <source/>Aging
<year>2017</year>; <volume>9</volume>: <fpage>419</fpage>–<lpage>446</lpage>.<pub-id pub-id-type="pmid">28198702</pub-id></mixed-citation>
</ref>
<ref id="bibr93-2045125318814734">
<label>93</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frieling</surname><given-names>H</given-names></name><name><surname>Bleich</surname><given-names>S</given-names></name><name><surname>Otten</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>Epigenetic downregulation of atrial natriuretic peptide but not vasopressin mRNA expression in females with eating disorders is related to impulsivity</article-title>. <source/>Neuropsychopharmacology
<year>2008</year>; <volume>33</volume>: <fpage>2605</fpage>–<lpage>2609</lpage>.<pub-id pub-id-type="pmid">18172431</pub-id></mixed-citation>
</ref>
<ref id="bibr94-2045125318814734">
<label>94</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frieling</surname><given-names>H</given-names></name><name><surname>Albrecht</surname><given-names>H</given-names></name><name><surname>Jedtberg</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Elevated cannabinoid 1 receptor mRNA is linked to eating disorder related behavior and attitudes in females with eating disorders</article-title>. <source/>Psychoneuroendocrinology
<year>2009</year>; <volume>34</volume>: <fpage>620</fpage>–<lpage>624</lpage>.<pub-id pub-id-type="pmid">19046818</pub-id></mixed-citation>
</ref>
<ref id="bibr95-2045125318814734">
<label>95</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ehrlich</surname><given-names>S</given-names></name><name><surname>Weiss</surname><given-names>D</given-names></name><name><surname>Burghardt</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Promoter specific DNA methylation and gene expression of POMC in acutely underweight and recovered patients with anorexia nervosa</article-title>. <source/>J Psychiatr Res
<year>2010</year>; <volume>44</volume>: <fpage>827</fpage>–<lpage>833</lpage>.<pub-id pub-id-type="pmid">20176366</pub-id></mixed-citation>
</ref>
<ref id="bibr96-2045125318814734">
<label>96</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frieling</surname><given-names>H</given-names></name><name><surname>Romer</surname><given-names>KD</given-names></name><name><surname>Scholz</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Epigenetic dysregulation of dopaminergic genes in eating disorders</article-title>. <source/>Int J Eat Disord
<year>2010</year>; <volume>43</volume>: <fpage>577</fpage>–<lpage>583</lpage>.<pub-id pub-id-type="pmid">19728374</pub-id></mixed-citation>
</ref>
<ref id="bibr97-2045125318814734">
<label>97</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Janas-Kozik</surname><given-names>M</given-names></name><name><surname>Stachowicz</surname><given-names>M</given-names></name><name><surname>Mazurek</surname><given-names>U</given-names></name><etal>et al</etal></person-group>
<article-title>Preliminary study of the expression of genes connected with the orexigenic and anorexigenic system using microarray technique in anorexia nervosa</article-title>. <source/>Neuropsychobiology
<year>2008</year>; <volume>57</volume>: <fpage>116</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">18552512</pub-id></mixed-citation>
</ref>
<ref id="bibr98-2045125318814734">
<label>98</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kahl</surname><given-names>KG</given-names></name><name><surname>Kruse</surname><given-names>N</given-names></name><name><surname>Rieckmann</surname><given-names>P</given-names></name><etal>et al</etal></person-group>
<article-title>Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa</article-title>. <source/>Psychoneuroendocrinology
<year>2004</year>; <volume>29</volume>: <fpage>13</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">14575726</pub-id></mixed-citation>
</ref>
<ref id="bibr99-2045125318814734">
<label>99</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mercader</surname><given-names>JM</given-names></name><name><surname>Saus</surname><given-names>E</given-names></name><name><surname>Agüera</surname><given-names>Z</given-names></name><etal>et al</etal></person-group>
<article-title>Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders</article-title>. <source/>Hum Mol Genet
<year>2008</year>; <volume>17</volume>: <fpage>1234</fpage>–<lpage>1244</lpage>.<pub-id pub-id-type="pmid">18203754</pub-id></mixed-citation>
</ref>
<ref id="bibr100-2045125318814734">
<label>100</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Urwin</surname><given-names>RE</given-names></name><name><surname>Nunn</surname><given-names>KP.</given-names></name></person-group>
<article-title>Epistatic interaction between the monoamine oxidase A and serotonin transporter genes in anorexia nervosa</article-title>. <source/>Eur J Hum Genet
<year>2005</year>; <volume>13</volume>: <fpage>370</fpage>–<lpage>375</lpage>.<pub-id pub-id-type="pmid">15523490</pub-id></mixed-citation>
</ref>
<ref id="bibr101-2045125318814734">
<label>101</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Moore</surname><given-names>J</given-names></name><name><surname>Ashimi</surname><given-names>SS</given-names></name><etal>et al</etal></person-group>
<article-title>Eating disorder predisposition is associated with ESRRA and HDAC4 mutations</article-title>. <source/>J Clin Invest
<year>2013</year>; <volume>123</volume>: <fpage>4706</fpage>–<lpage>4713</lpage>.<pub-id pub-id-type="pmid">24216484</pub-id></mixed-citation>
</ref>
<ref id="bibr102-2045125318814734">
<label>102</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fenech</surname><given-names>M</given-names></name><name><surname>El-Sohemy</surname><given-names>A</given-names></name><name><surname>Cahill</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Nutrigenetics and nutrigenomics: viewpoints on the current status and applications in nutrition research and practice</article-title>. <source/>J Nutrigenet Nutrigenomics
<year>2011</year>; <volume>4</volume>: <fpage>69</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">21625170</pub-id></mixed-citation>
</ref>
<ref id="bibr103-2045125318814734">
<label>103</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mutch</surname><given-names>DM</given-names></name><name><surname>Wahli</surname><given-names>W</given-names></name><name><surname>Williamson</surname><given-names>G.</given-names></name></person-group>
<article-title>Nutrigenomics and nutrigenetics: the emerging faces of nutrition</article-title>. <source/>FASEB J
<year>2005</year>; <volume>19</volume>: <fpage>1602</fpage>–<lpage>1616</lpage>.<pub-id pub-id-type="pmid">16195369</pub-id></mixed-citation>
</ref>
<ref id="bibr104-2045125318814734">
<label>104</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scott-Van Zeeland</surname><given-names>AA</given-names></name><name><surname>Bloss</surname><given-names>CS</given-names></name><name><surname>Tewhey</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Evidence for the role of EPHX2 gene variants in anorexia nervosa</article-title>. <source/>Mol Psychiatry
<year>2014</year>; <volume>19</volume>: <fpage>724</fpage>–<lpage>732</lpage>.<pub-id pub-id-type="pmid">23999524</pub-id></mixed-citation>
</ref>
<ref id="bibr105-2045125318814734">
<label>105</label>
<mixed-citation publication-type="confproc">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Hammock</surname><given-names>BD</given-names></name><name><surname>Halmi</surname><given-names>KA</given-names></name><etal>et al</etal></person-group>
<article-title>Substrate-dependent postprandial oxylipin responses reveal the potential role of nutrient-gene interaction in Anorexia Nervosa</article-title>. <conf-name>Paper presented at the American College of Neuropsychopharmacology Annual Meeting</conf-name>, <conf-date>2015</conf-date>, <conf-loc>Hollywood, US</conf-loc>.</mixed-citation>
</ref>
<ref id="bibr106-2045125318814734">
<label>106</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lozupone</surname><given-names>CA</given-names></name><name><surname>Stombaugh</surname><given-names>JI</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name><etal>et al</etal></person-group>
<article-title>Diversity, stability and resilience of the human gut microbiota</article-title>. <source/>Nature
<year>2012</year>; <volume>489</volume>: <fpage>220</fpage>–<lpage>230</lpage>.<pub-id pub-id-type="pmid">22972295</pub-id></mixed-citation>
</ref>
<ref id="bibr107-2045125318814734">
<label>107</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>DF</given-names></name><name><surname>Cain</surname><given-names>NE</given-names></name><name><surname>Boon</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder</article-title>. <source/>Behav Brain Res
<year>2011</year>; <volume>217</volume>: <fpage>47</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">20937326</pub-id></mixed-citation>
</ref>
<ref id="bibr108-2045125318814734">
<label>108</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ríos-Covián</surname><given-names>D</given-names></name><name><surname>Ruas-Madiedo</surname><given-names>P</given-names></name><name><surname>Margolles</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Intestinal short chain fatty acids and their link with diet and human health</article-title>. <source/>Front Microbiol
<year>2016</year>; <volume>7</volume>: <fpage>185</fpage>.<pub-id pub-id-type="pmid">26925050</pub-id></mixed-citation>
</ref>
<ref id="bibr109-2045125318814734">
<label>109</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Topping</surname><given-names>DL</given-names></name><name><surname>Clifton</surname><given-names>PM.</given-names></name></person-group>
<article-title>Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides</article-title>. <source/>Physiol Rev
<year>2001</year>; <volume>81</volume>: <fpage>1031</fpage>–<lpage>1064</lpage>.<pub-id pub-id-type="pmid">11427691</pub-id></mixed-citation>
</ref>
<ref id="bibr110-2045125318814734">
<label>110</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waldecker</surname><given-names>M</given-names></name><name><surname>Kautenburger</surname><given-names>T</given-names></name><name><surname>Daumann</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Histone-deacetylase inhibition and butyrate formation: fecal slurry incubations with apple pectin and apple juice extracts</article-title>. <source/>Nutrition
<year>2008</year>; <volume>24</volume>: <fpage>366</fpage>–<lpage>374</lpage>.<pub-id pub-id-type="pmid">18262392</pub-id></mixed-citation>
</ref>
<ref id="bibr111-2045125318814734">
<label>111</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Puertollano</surname><given-names>E</given-names></name><name><surname>Kolida</surname><given-names>S</given-names></name><name><surname>Yaqoob</surname><given-names>P.</given-names></name></person-group>
<article-title>Biological significance of short-chain fatty acid metabolism by the intestinal microbiome</article-title>. <source/>Curr Opin Clin Nutr Metab Care
<year>2014</year>; <volume>17</volume>: <fpage>139</fpage>–<lpage>144</lpage>.<pub-id pub-id-type="pmid">24389673</pub-id></mixed-citation>
</ref>
<ref id="bibr112-2045125318814734">
<label>112</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pfleiderer</surname><given-names>A</given-names></name><name><surname>Lagier</surname><given-names>JC</given-names></name><name><surname>Armougom</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Culturomics identified 11 new bacterial species from a single anorexia nervosa stool sample</article-title>. <source/>Eur J Clin Microbiol Infect Dis
<year>2013</year>; <volume>32</volume>: <fpage>1471</fpage>–<lpage>1481</lpage>.<pub-id pub-id-type="pmid">23728738</pub-id></mixed-citation>
</ref>
<ref id="bibr113-2045125318814734">
<label>113</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raybould</surname><given-names>HE.</given-names></name></person-group>
<article-title>Gut chemosensing: interactions between gut endocrine cells and visceral afferents</article-title>. <source/>Auton Neurosci
<year>2010</year>; <volume>153</volume>: <fpage>41</fpage>–<lpage>46</lpage>.<pub-id pub-id-type="pmid">19674941</pub-id></mixed-citation>
</ref>
<ref id="bibr114-2045125318814734">
<label>114</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banks</surname><given-names>WA</given-names></name><name><surname>Gray</surname><given-names>AM</given-names></name><name><surname>Erickson</surname><given-names>MA</given-names></name><etal>et al</etal></person-group>
<article-title>Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit</article-title>. <source/>J Neuroinflammation
<year>2015</year>; <volume>12</volume>: <fpage>223</fpage>.<pub-id pub-id-type="pmid">26608623</pub-id></mixed-citation>
</ref>
<ref id="bibr115-2045125318814734">
<label>115</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alcock</surname><given-names>J</given-names></name><name><surname>Maley</surname><given-names>CC</given-names></name><name><surname>Aktipis</surname><given-names>CA.</given-names></name></person-group>
<article-title>Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms</article-title>. <source/>Bioessays
<year>2014</year>; <volume>36</volume>: <fpage>940</fpage>–<lpage>949</lpage>.<pub-id pub-id-type="pmid">25103109</pub-id></mixed-citation>
</ref>
<ref id="bibr116-2045125318814734">
<label>116</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fetissov</surname><given-names>SO</given-names></name><name><surname>Hallman</surname><given-names>J</given-names></name><name><surname>Oreland</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>Autoantibodies against alpha-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients</article-title>. <source/>Proc Natl Acad Sci USA
<year>2002</year>; <volume>99</volume>: <fpage>17155</fpage>–<lpage>17160</lpage>.<pub-id pub-id-type="pmid">12486250</pub-id></mixed-citation>
</ref>
<ref id="bibr117-2045125318814734">
<label>117</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fetissov</surname><given-names>SO</given-names></name><name><surname>Harro</surname><given-names>J</given-names></name><name><surname>Jaanisk</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Autoantibodies against neuropeptides are associated with psychological traits in eating disorders</article-title>. <source/>Proc Natl Acad Sci USA
<year>2005</year>; <volume>102</volume>: <fpage>14865</fpage>–<lpage>14870</lpage>.<pub-id pub-id-type="pmid">16195379</pub-id></mixed-citation>
</ref>
<ref id="bibr118-2045125318814734">
<label>118</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Armougom</surname><given-names>F</given-names></name><name><surname>Henry</surname><given-names>M</given-names></name><name><surname>Vialettes</surname><given-names>B</given-names></name><etal>et al</etal></person-group>
<article-title>Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients</article-title>. <source/>PLoS One
<year>2009</year>; <volume>4</volume>: <fpage>e7125</fpage>.<pub-id pub-id-type="pmid">19774074</pub-id></mixed-citation>
</ref>
<ref id="bibr119-2045125318814734">
<label>119</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mack</surname><given-names>I</given-names></name><name><surname>Cuntz</surname><given-names>U</given-names></name><name><surname>Grämer</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints</article-title>. <source/>Sci Rep
<year>2016</year>; <volume>6</volume>: <fpage>26752</fpage>.<pub-id pub-id-type="pmid">27229737</pub-id></mixed-citation>
</ref>
<ref id="bibr120-2045125318814734">
<label>120</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morita</surname><given-names>C</given-names></name><name><surname>Tsuji</surname><given-names>H</given-names></name><name><surname>Hata</surname><given-names>T</given-names></name><etal>et al</etal></person-group>
<article-title>Gut dysbiosis in patients with anorexia nervosa</article-title>. <source/>PLoS One
<year>2015</year>; <volume>10</volume>: <fpage>e0145274</fpage>.<pub-id pub-id-type="pmid">26682545</pub-id></mixed-citation>
</ref>
<ref id="bibr121-2045125318814734">
<label>121</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Breton</surname><given-names>J</given-names></name><name><surname>Legrand</surname><given-names>R</given-names></name><name><surname>Akkermann</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Elevated plasma concentrations of bacterial ClpB protein in patients with eating disorders</article-title>. <source/>Int J Eat Disord
<year>2016</year>; <volume>49</volume>: <fpage>805</fpage>–<lpage>808</lpage>.<pub-id pub-id-type="pmid">27038326</pub-id></mixed-citation>
</ref>
<ref id="bibr122-2045125318814734">
<label>122</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raevuori</surname><given-names>A</given-names></name><name><surname>Lukkariniemi</surname><given-names>L</given-names></name><name><surname>Suokas</surname><given-names>JT</given-names></name><etal>et al</etal></person-group>
<article-title>Increased use of antimicrobial medication in bulimia nervosa and binge-eating disorder prior to the eating disorder treatment</article-title>. <source/>Int J Eat Disord
<year>2016</year>; <volume>49</volume>: <fpage>542</fpage>–<lpage>552</lpage>.<pub-id pub-id-type="pmid">26875554</pub-id></mixed-citation>
</ref>
<ref id="bibr123-2045125318814734">
<label>123</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levine</surname><given-names>MP</given-names></name><name><surname>Smolak</surname><given-names>L</given-names></name><name><surname>Moodey</surname><given-names>AF</given-names></name><etal>et al</etal></person-group>
<article-title>Normative developmental challenges and dieting and eating disturbances in middle school girls</article-title>. <source/>Int J Eat Disord
<year>1994</year>; <volume>15</volume>: <fpage>11</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">8124323</pub-id></mixed-citation>
</ref>
<ref id="bibr124-2045125318814734">
<label>124</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>MN</given-names></name><name><surname>Pumariega</surname><given-names>AJ.</given-names></name></person-group>
<article-title>Culture and eating disorders: a historical and cross-cultural review</article-title>. <source/>Psychiatry
<year>2001</year>; <volume>64</volume>: <fpage>93</fpage>–<lpage>110</lpage>.<pub-id pub-id-type="pmid">11495364</pub-id></mixed-citation>
</ref>
<ref id="bibr125-2045125318814734">
<label>125</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yacoub</surname><given-names>R</given-names></name><name><surname>Kaji</surname><given-names>D</given-names></name><name><surname>Patel</surname><given-names>SN</given-names></name><etal>et al</etal></person-group>
<article-title>Association between probiotic and yogurt consumption and kidney disease: insights from NHANES</article-title>. <source/>Nutr J
<year>2016</year>; <volume>15</volume>: <fpage>10</fpage>.<pub-id pub-id-type="pmid">26818246</pub-id></mixed-citation>
</ref>
<ref id="bibr126-2045125318814734">
<label>126</label>
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Faith</surname><given-names>MS</given-names></name><name><surname>Kral</surname><given-names>TVE</given-names></name></person-group>
<article-title>Social environmental and genetic influences on obesity and obesity-promoting behaviors: fostering research integration</article-title>. In: <source/>Genes, behavior, and the social environment: moving beyond the nature/nurture debate. <publisher-name>National Academy of Sciences</publisher-name>, <year>2006</year>.</mixed-citation>
</ref>
<ref id="bibr127-2045125318814734">
<label>127</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>MC</given-names></name><name><surname>Barnes</surname><given-names>JH</given-names><suffix>Jr</suffix></name><etal>et al</etal></person-group>
<article-title>Meta-analysis of correlates of diabetes patients’ compliance with prescribed medications</article-title>. <source/>Diabetes Educ
<year>1990</year>; <volume>16</volume>: <fpage>192</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">2139601</pub-id></mixed-citation>
</ref>
<ref id="bibr128-2045125318814734">
<label>128</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosi</surname><given-names>A</given-names></name><name><surname>Mena</surname><given-names>P</given-names></name><name><surname>Pellegrini</surname><given-names>N</given-names></name><etal>et al</etal></person-group>
<article-title>Environmental impact of omnivorous, ovo-lacto-vegetarian, and vegan diet</article-title>. <source/>Sci Rep
<year>2017</year>; <volume>7</volume>: <fpage>6105</fpage>.<pub-id pub-id-type="pmid">28733610</pub-id></mixed-citation>
</ref>
<ref id="bibr129-2045125318814734">
<label>129</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Copeland</surname><given-names>WE</given-names></name><name><surname>Bulik</surname><given-names>CM</given-names></name><name><surname>Zucker</surname><given-names>N</given-names></name><etal>et al</etal></person-group>
<article-title>Does childhood bullying predict eating disorder symptoms? A prospective, longitudinal analysis</article-title>. <source/>Int J Eat Disord
<year>2015</year>; <volume>48</volume>: <fpage>1141</fpage>–<lpage>1149</lpage>.<pub-id pub-id-type="pmid">26337405</pub-id></mixed-citation>
</ref>
<ref id="bibr130-2045125318814734">
<label>130</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lloyd</surname><given-names>EC</given-names></name><name><surname>Frampton</surname><given-names>I</given-names></name><name><surname>Verplanken</surname><given-names>B</given-names></name><etal>et al</etal></person-group>
<article-title>How extreme dieting becomes compulsive: a novel hypothesis for the role of anxiety in the development and maintenance of anorexia nervosa</article-title>. <source/>Med Hypotheses
<year>2017</year>; <volume>108</volume>: <fpage>144</fpage>–<lpage>150</lpage>.<pub-id pub-id-type="pmid">29055388</pub-id></mixed-citation>
</ref>
<ref id="bibr131-2045125318814734">
<label>131</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sokol</surname><given-names>MS.</given-names></name></person-group>
<article-title>Infection-triggered anorexia nervosa in children: clinical description of four cases</article-title>. <source/>J Child Adolesc Psychopharmacol
<year>2000</year>; <volume>10</volume>: <fpage>133</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">10933123</pub-id></mixed-citation>
</ref>
<ref id="bibr132-2045125318814734">
<label>132</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>MW</given-names></name><name><surname>Woods</surname><given-names>SC</given-names></name><name><surname>Porte</surname><given-names>D</given-names><suffix>Jr</suffix></name><etal>et al</etal></person-group>
<article-title>Central nervous system control of food intake</article-title>. <source/>Nature
<year>2000</year>; <volume>404</volume>: <fpage>661</fpage>–<lpage>671</lpage>.<pub-id pub-id-type="pmid">10766253</pub-id></mixed-citation>
</ref>
<ref id="bibr133-2045125318814734">
<label>133</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Capuron</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>AH.</given-names></name></person-group>
<article-title>Immune system to brain signaling: neuropsychopharmacological implications</article-title>. <source/>Pharmacol Ther
<year>2011</year>; <volume>130</volume>: <fpage>226</fpage>–<lpage>238</lpage>.<pub-id pub-id-type="pmid">21334376</pub-id></mixed-citation>
</ref>
<ref id="bibr134-2045125318814734">
<label>134</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lichtblau</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>FM</given-names></name><name><surname>Schumann</surname><given-names>R</given-names></name><etal>et al</etal></person-group>
<article-title>Cytokines as biomarkers in depressive disorder: current standing and prospects</article-title>. <source/>Int Rev Psychiatry
<year>2013</year>; <volume>25</volume>: <fpage>592</fpage>–<lpage>603</lpage>.<pub-id pub-id-type="pmid">24151804</pub-id></mixed-citation>
</ref>
<ref id="bibr135-2045125318814734">
<label>135</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Himmerich</surname><given-names>H</given-names></name><name><surname>Fischer</surname><given-names>J</given-names></name><name><surname>Bauer</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>Stress-induced cytokine changes in rats</article-title>. <source/>Eur Cytokine Netw
<year>2013</year>; <volume>24</volume>: <fpage>97</fpage>–<lpage>103</lpage>.<pub-id pub-id-type="pmid">23823083</pub-id></mixed-citation>
</ref>
<ref id="bibr136-2045125318814734">
<label>136</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krügel</surname><given-names>U</given-names></name><name><surname>Fischer</surname><given-names>J</given-names></name><name><surname>Bauer</surname><given-names>K</given-names></name><etal>et al</etal></person-group>
<article-title>The impact of social isolation on immunological parameters in rats</article-title>. <source/>Arch Toxicol
<year>2014</year>; <volume>88</volume>: <fpage>853</fpage>–<lpage>855</lpage>.<pub-id pub-id-type="pmid">24500571</pub-id></mixed-citation>
</ref>
<ref id="bibr137-2045125318814734">
<label>137</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gruen</surname><given-names>JR</given-names></name><name><surname>Weissman</surname><given-names>SM.</given-names></name></person-group>
<article-title>Human MHC class III and IV genes and disease associations</article-title>. <source/>Front Biosci
<year>2001</year>; <volume>6</volume>: <fpage>960</fpage>–<lpage>972</lpage>.</mixed-citation>
</ref>
<ref id="bibr138-2045125318814734">
<label>138</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sekar</surname><given-names>A</given-names></name><name><surname>Bialas</surname><given-names>AR</given-names></name><name><surname>de Rivera</surname><given-names>H</given-names></name><etal>et al</etal></person-group>
<article-title>Schizophrenia risk from complex variation of complement component 4</article-title>. <source/>Nature
<year>2016</year>; <volume>530</volume>: <fpage>177</fpage>–<lpage>183</lpage>.<pub-id pub-id-type="pmid">26814963</pub-id></mixed-citation>
</ref>
<ref id="bibr139-2045125318814734">
<label>139</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Solmi</surname><given-names>M</given-names></name><name><surname>Veronese</surname><given-names>N</given-names></name><name><surname>Favaro</surname><given-names>A</given-names></name><etal>et al</etal></person-group>
<article-title>Inflammatory cytokines and anorexia nervosa: a meta-analysis of cross-sectional and longitudinal studies</article-title>. <source/>Psychoneuroendocrinology
<year>2015</year>; <volume>51</volume>: <fpage>237</fpage>–<lpage>252</lpage>.<pub-id pub-id-type="pmid">25462897</pub-id></mixed-citation>
</ref>
<ref id="bibr140-2045125318814734">
<label>140</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dalton</surname><given-names>B</given-names></name><name><surname>Bartholdy</surname><given-names>S</given-names></name><name><surname>Robinson</surname><given-names>L</given-names></name><etal>et al</etal></person-group>
<article-title>A meta-analysis of cytokine concentrations in eating disorders</article-title>. <source/>J Psychiatr Res
<year>2018</year>; <volume>103</volume>: <fpage>252</fpage>–<lpage>264</lpage>.<pub-id pub-id-type="pmid">29906710</pub-id></mixed-citation>
</ref>
<ref id="bibr141-2045125318814734">
<label>141</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krügel</surname><given-names>U</given-names></name><name><surname>Fischer</surname><given-names>J</given-names></name><name><surname>Radicke</surname><given-names>S</given-names></name><etal>et al</etal></person-group>
<article-title>Antidepressant effects of TNF-alpha blockade in an animal model of depression</article-title>. <source/>J Psychiatr Res
<year>2013</year>; <volume>47</volume>: <fpage>611</fpage>–<lpage>616</lpage>.<pub-id pub-id-type="pmid">23394815</pub-id></mixed-citation>
</ref>
<ref id="bibr142-2045125318814734">
<label>142</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sherwin</surname><given-names>E</given-names></name><name><surname>Rea</surname><given-names>K</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><etal>et al</etal></person-group>
<article-title>A gut (microbiome) feeling about the brain</article-title>. <source/>Curr Opin Gastroenterol
<year>2016</year>; <volume>32</volume>: <fpage>96</fpage>–<lpage>102</lpage>.<pub-id pub-id-type="pmid">26760398</pub-id></mixed-citation>
</ref>
<ref id="bibr143-2045125318814734">
<label>143</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>FM</given-names></name><name><surname>Lichtblau</surname><given-names>N</given-names></name><name><surname>Minkwitz</surname><given-names>J</given-names></name><etal>et al</etal></person-group>
<article-title>Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity</article-title>. <source/>J Psychiatr Res
<year>2014</year>; <volume>55</volume>: <fpage>29</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">24838047</pub-id></mixed-citation>
</ref>
<ref id="bibr144-2045125318814734">
<label>144</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waheed</surname><given-names>A</given-names></name><name><surname>Dalton</surname><given-names>B</given-names></name><name><surname>Wesemann</surname><given-names>U</given-names></name><etal>et al</etal></person-group>
<article-title>A systematic review of interleukin-1β in post-traumatic stress disorder: evidence from human and animal studies</article-title>. <source/>J Interferon Cytokine Res
<year>2018</year>; <volume>38</volume>: <fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">29328883</pub-id></mixed-citation>
</ref>
<ref id="bibr145-2045125318814734">
<label>145</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hussein</surname><given-names>S</given-names></name><name><surname>Dalton</surname><given-names>B</given-names></name><name><surname>Willmund</surname><given-names>GD</given-names></name><etal>et al</etal></person-group>
<article-title>A systematic review of tumor necrosis factor-α in post-traumatic stress disorder: evidence from human and animal studies</article-title>. <source/>Psychiatr Danub
<year>2017</year>; <volume>29</volume>: <fpage>407</fpage>–<lpage>420</lpage>.<pub-id pub-id-type="pmid">29197197</pub-id></mixed-citation>
</ref>
<ref id="bibr146-2045125318814734">
<label>146</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Müller</surname><given-names>N</given-names></name><name><surname>Weidinger</surname><given-names>E</given-names></name><name><surname>Leitner</surname><given-names>B</given-names></name><etal>et al</etal></person-group>
<article-title>The role of inflammation in schizophrenia</article-title>. <source/>Front Neurosci
<year>2015</year>; <volume>9</volume>: <fpage>372</fpage>.<pub-id pub-id-type="pmid">26539073</pub-id></mixed-citation>
</ref>
<ref id="bibr147-2045125318814734">
<label>147</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borovcanin</surname><given-names>M</given-names></name><name><surname>Jovanovic</surname><given-names>I</given-names></name><name><surname>Dejanovic</surname><given-names>SD</given-names></name><etal>et al</etal></person-group>
<article-title>Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia</article-title>. <source/>Psychoneuroendocrinology
<year>2015</year>; <volume>56</volume>: <fpage>143</fpage>–<lpage>147</lpage>.<pub-id pub-id-type="pmid">25827958</pub-id></mixed-citation>
</ref>
<ref id="bibr148-2045125318814734">
<label>148</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kapcala</surname><given-names>LP</given-names></name><name><surname>Chautard</surname><given-names>T</given-names></name><name><surname>Eskay</surname><given-names>RL.</given-names></name></person-group>
<article-title>The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress</article-title>. <source/>Ann N Y Acad Sci
<year>1995</year>; <volume>771</volume>: <fpage>419</fpage> –<lpage>437</lpage>.<pub-id pub-id-type="pmid">8597419</pub-id></mixed-citation>
</ref>
<ref id="bibr149-2045125318814734">
<label>149</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tilders</surname><given-names>FJ</given-names></name><name><surname>DeRijk</surname><given-names>RH</given-names></name><name><surname>Van Dam</surname><given-names>AM</given-names></name><etal>et al</etal></person-group>
<article-title>Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals</article-title>. <source/>Psychoneuroendocrinology
<year>1994</year>; <volume>9</volume>: <fpage>209</fpage> –<lpage>232</lpage>.</mixed-citation>
</ref>
<ref id="bibr150-2045125318814734">
<label>150</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silverman</surname><given-names>MN</given-names></name><name><surname>Pearce</surname><given-names>BD</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name><etal>et al</etal></person-group>
<article-title>Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection</article-title>. <source/>Viral Immunol
<year>2005</year>; <volume>18</volume>: <fpage>41</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">15802953</pub-id></mixed-citation>
</ref>
<ref id="bibr151-2045125318814734">
<label>151</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Himmerich</surname><given-names>H</given-names></name><name><surname>Binder</surname><given-names>EB</given-names></name><name><surname>Künzel</surname><given-names>HE</given-names></name><etal>et al</etal></person-group>
<article-title>Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis</article-title>. <source/>Biol Psychiatry
<year>2006</year>; <volume>60</volume>: <fpage>882</fpage>–<lpage>888</lpage>.<pub-id pub-id-type="pmid">16989778</pub-id></mixed-citation>
</ref>
<ref id="bibr152-2045125318814734">
<label>152</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arzt</surname><given-names>E</given-names></name><name><surname>Kovalovsky</surname><given-names>D</given-names></name><name><surname>IgazL</surname><given-names>M</given-names></name><etal>et al</etal></person-group>
<article-title>Functional cross-talk among cytokines, T-cell receptor, and glucocorticoid receptor transcriptional activity and action</article-title>. <source/>Ann N Y Acad Sci
<year>2000</year>; <volume>917</volume>: <fpage>672</fpage>–<lpage>677</lpage>.<pub-id pub-id-type="pmid">11268396</pub-id></mixed-citation>
</ref>
<ref id="bibr153-2045125318814734">
<label>153</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Besedovsky</surname><given-names>HO</given-names></name><name><surname>Del Rey</surname><given-names>A.</given-names></name></person-group>
<article-title>The cytokine-HPA axis feed-back circuit</article-title>. <source/>Z Rheumatol
<year>2000</year>; <volume>59</volume>(<issue>Suppl. 2</issue>): <fpage>26</fpage> –<lpage>30</lpage>.</mixed-citation>
</ref>
<ref id="bibr154-2045125318814734">
<label>154</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reul</surname><given-names>JM</given-names></name><name><surname>Labeur</surname><given-names>MS</given-names></name><name><surname>Wiegers</surname><given-names>GJ</given-names></name><etal>et al</etal></person-group>
<article-title>Altered neuroimmunoendocrine communication during a condition of chronically increased brain corticotropin-releasing hormone drive</article-title>. <source/>Ann N Y Acad Sci
<year>1998</year>; <volume>840</volume>: <fpage>444</fpage>–<lpage>455</lpage>.<pub-id pub-id-type="pmid">9629271</pub-id></mixed-citation>
</ref>
<ref id="bibr155-2045125318814734">
<label>155</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schöbitz</surname><given-names>B</given-names></name><name><surname>Reul</surname><given-names>JM</given-names></name><name><surname>Holsboer</surname><given-names>F.</given-names></name></person-group>
<article-title>The role of the hypothalamic-pituitary-adrenocortical system during inflammatory conditions</article-title>. <source/>Crit Rev Neurobiol
<year>1994</year>; <volume>8</volume>: <fpage>263</fpage>–<lpage>291</lpage>.<pub-id pub-id-type="pmid">7850874</pub-id></mixed-citation>
</ref>
<ref id="bibr156-2045125318814734">
<label>156</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Staurenghi</surname><given-names>AH</given-names></name><name><surname>Masera</surname><given-names>RG</given-names></name><name><surname>Prolo</surname><given-names>P</given-names></name><etal>et al</etal></person-group>
<article-title>Hypothalamic-pituitary-adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa</article-title>. <source/>Psychoneuroendocrinology
<year>1997</year>; <volume>22</volume>: <fpage>575</fpage>–<lpage>590</lpage>.<pub-id pub-id-type="pmid">9483703</pub-id></mixed-citation>
</ref>
<ref id="bibr157-2045125318814734">
<label>157</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Limone</surname><given-names>P</given-names></name><name><surname>Biglino</surname><given-names>A</given-names></name><name><surname>Bottino</surname><given-names>F</given-names></name><etal>et al</etal></person-group>
<article-title>Evidence for a positive correlation between serum cortisol levels and IL-1beta production by peripheral mononuclear cells in anorexia nervosa</article-title>. <source/>J Endocrinol Invest
<year>2000</year>; <volume>23</volume>: <fpage>422</fpage>–<lpage>427</lpage>.<pub-id pub-id-type="pmid">11005265</pub-id></mixed-citation>
</ref>
<ref id="bibr158-2045125318814734">
<label>158</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Corcos</surname><given-names>M</given-names></name><name><surname>Flament</surname><given-names>MF</given-names></name><name><surname>Giraud</surname><given-names>MJ</given-names></name><etal>et al</etal></person-group>
<article-title>Early psychopathological signs in bulimia nervosa. A retrospective comparison of the period of puberty in bulimic and control girls</article-title>. <source/>Eur Child Adolesc Psychiatry
<year>2000</year>; <volume>9</volume>: <fpage>115</fpage>–<lpage>121</lpage>.<pub-id pub-id-type="pmid">10926061</pub-id></mixed-citation>
</ref>
<ref id="bibr159-2045125318814734">
<label>159</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Medland</surname><given-names>SE</given-names></name><name><surname>Jahanshad</surname><given-names>N</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><etal>et al</etal></person-group>
<article-title>Whole-genome analyses of whole-brain data: working within an expanded search space</article-title>. <source/>Nat Neurosci
<year>2014</year>; <volume>17</volume>: <fpage>791</fpage>–<lpage>800</lpage>.<pub-id pub-id-type="pmid">24866045</pub-id></mixed-citation>
</ref>
<ref id="bibr160-2045125318814734">
<label>160</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frank</surname><given-names>GK.</given-names></name></person-group>
<article-title>Advances from neuroimaging studies in eating disorders</article-title>. <source/>CNS Spectr
<year>2015</year>; <volume>20</volume>: <fpage>391</fpage>–<lpage>400</lpage>.<pub-id pub-id-type="pmid">25902917</pub-id></mixed-citation>
</ref>
<ref id="bibr161-2045125318814734">
<label>161</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>King</surname><given-names>JA</given-names></name><name><surname>Frank</surname><given-names>GKW</given-names></name><name><surname>Thompson</surname><given-names>PM</given-names></name><etal>et al</etal></person-group>
<article-title>Structural neuroimaging of anorexia nervosa: future directions in the quest for mechanisms underlying dynamic alterations</article-title>. <source/>Biol Psychiatry
<year>2018</year>; <volume>83</volume>: <fpage>224</fpage>–<lpage>234</lpage>.<pub-id pub-id-type="pmid">28967386</pub-id></mixed-citation>
</ref>
<ref id="bibr162-2045125318814734">
<label>162</label>
<mixed-citation publication-type="web">
<collab>The ENIGMA Consortium</collab>. <article-title>Enhancing Neuro Imaging Genetics by MetaAnalysis</article-title>, <ext-link ext-link-type="uri" xlink:href="http://enigma.ini.usc.edu/">http://enigma.ini.usc.edu/</ext-link> (<comment>accessed 5 September 2018</comment>).</mixed-citation>
</ref>
<ref id="bibr163-2045125318814734">
<label>163</label>
<mixed-citation publication-type="web">
<collab>University of Bristol</collab>. <article-title>Avon Longitudinal Study of Parents and Children</article-title>, <ext-link ext-link-type="uri" xlink:href="http://www.bristol.ac.uk/alspac/">http://www.bristol.ac.uk/alspac/</ext-link> (<comment>accessed 5 September 2018</comment>).</mixed-citation>
</ref>
<ref id="bibr164-2045125318814734">
<label>164</label>
<mixed-citation publication-type="web">
<collab>Norwegian Institute of Public Health</collab>. <article-title>Norwegian Mother and Child Cohort Study</article-title>, <ext-link ext-link-type="uri" xlink:href="https://www.fhi.no/en/studies/moba/">https://www.fhi.no/en/studies/moba/</ext-link> (<comment>accessed 5 September 2018</comment>).</mixed-citation>
</ref>
<ref id="bibr165-2045125318814734">
<label>165</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thornton</surname><given-names>LM</given-names></name><name><surname>Munn-Chernoff</surname><given-names>MA</given-names></name><name><surname>Baker</surname><given-names>JH</given-names></name><etal>et al</etal></person-group>
<article-title>The Anorexia Nervosa Genetics Initiative (ANGI): Overview and methods</article-title>. <source/>Contemp Clin Trials
<year>2018</year>; <volume>74</volume>: <fpage>61</fpage>–<lpage>69</lpage>.<pub-id pub-id-type="pmid">30287268</pub-id></mixed-citation>
</ref>
<ref id="bibr166-2045125318814734">
<label>166</label>
<mixed-citation publication-type="web">
<collab>Charlotte’s Helix Team</collab>. <article-title>Charlotte’s Helix Project</article-title>, <ext-link ext-link-type="uri" xlink:href="https://www.charlotteshelix.net/">https://www.charlotteshelix.net/</ext-link> (<comment>accessed 5 September 2018</comment>).</mixed-citation>
</ref>
<ref id="bibr167-2045125318814734">
<label>167</label>
<mixed-citation publication-type="web">
<person-group person-group-type="author"><name><surname>Bulik</surname><given-names>C.</given-names></name></person-group>
<article-title>The Binge Eating Genetics INitiative</article-title>, <ext-link ext-link-type="uri" xlink:href="https://walkforhope.com/begin-binge-eating-genetics-initiative/">https://walkforhope.com/begin-binge-eating-genetics-initiative/</ext-link> (<comment>accessed 5 September 2018</comment>).</mixed-citation>
</ref>
<ref id="bibr168-2045125318814734">
<label>168</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thornton</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>P.</given-names></name></person-group>
<article-title>Publication bias in meta-analysis: its causes and consequences</article-title>. <source/>J Clin Epidemiol
<year>2000</year>; <volume>53</volume>: <fpage>207</fpage>–<lpage>216</lpage>.<pub-id pub-id-type="pmid">10729693</pub-id></mixed-citation>
</ref>
<ref id="bibr169-2045125318814734">
<label>169</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duncan</surname><given-names>LE</given-names></name><name><surname>Keller</surname><given-names>MC.</given-names></name></person-group>
<article-title>A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry</article-title>. <source/>Am J Psychiatry
<year>2011</year>; <volume>168</volume>: <fpage>1041</fpage>–<lpage>1049</lpage>.<pub-id pub-id-type="pmid">21890791</pub-id></mixed-citation>
</ref>
<ref id="bibr170-2045125318814734">
<label>170</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Coburn</surname><given-names>KM</given-names></name><name><surname>Vevea</surname><given-names>JL.</given-names></name></person-group>
<article-title>Publication bias as a function of study characteristics</article-title>. <source/>Psychol Methods
<year>2015</year>; <volume>20</volume>: <fpage>310</fpage>–<lpage>330</lpage>.<pub-id pub-id-type="pmid">26348731</pub-id></mixed-citation>
</ref>
<ref id="bibr171-2045125318814734">
<label>171</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luborsky</surname><given-names>L</given-names></name><name><surname>Barrett</surname><given-names>MS.</given-names></name></person-group>
<article-title>The history and empirical status of key psychoanalytic concepts</article-title>. <source/>Annu Rev Clin Psychol
<year>2006</year>; <volume>2</volume>: <fpage>1</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">17716062</pub-id></mixed-citation>
</ref>
<ref id="bibr172-2045125318814734">
<label>172</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Steinberg</surname><given-names>H</given-names></name><name><surname>Himmerich</surname><given-names>H.</given-names></name></person-group>
<article-title>Roland Kuhn-100th birthday of an innovator of clinical psychopharmacology</article-title>. <source/>Psychopharmacol Bull
<year>2012</year>; <volume>45</volume>: <fpage>48</fpage>–<lpage>50</lpage>.<pub-id pub-id-type="pmid">27738369</pub-id></mixed-citation>
</ref>
<ref id="bibr173-2045125318814734">
<label>173</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>FM</given-names></name><name><surname>Kirkby</surname><given-names>KC</given-names></name><name><surname>Himmerich</surname><given-names>H.</given-names></name></person-group>
<article-title>The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases</article-title>. <source/>Psychiatr Danub
<year>2014</year>; <volume>26</volume>: <fpage>288</fpage>–<lpage>290</lpage>.<pub-id pub-id-type="pmid">25191779</pub-id></mixed-citation>
</ref>
<ref id="bibr174-2045125318814734">
<label>174</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Zeng</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><etal>et al</etal></person-group>
<article-title>Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism</article-title>. <source/>Mol Psychiatry
<year>2016</year>; <volume>21</volume>: <fpage>786</fpage>–<lpage>796</lpage>.<pub-id pub-id-type="pmid">27067014</pub-id></mixed-citation>
</ref>
<ref id="bibr175-2045125318814734">
<label>175</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kantak</surname><given-names>PA</given-names></name><name><surname>Bobrow</surname><given-names>DN</given-names></name><name><surname>Nyby</surname><given-names>JG.</given-names></name></person-group>
<article-title>Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG)</article-title>.<source/>Behav Pharmacol
<year>2014</year>; <volume>25</volume>: <fpage>71</fpage>–<lpage>79</lpage>.<pub-id pub-id-type="pmid">24257436</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>